US20050174535A1 - Apparatus and method for determining subjective responses using objective characterization of vision based on wavefront sensing - Google Patents

Apparatus and method for determining subjective responses using objective characterization of vision based on wavefront sensing Download PDF

Info

Publication number
US20050174535A1
US20050174535A1 US10/653,552 US65355203A US2005174535A1 US 20050174535 A1 US20050174535 A1 US 20050174535A1 US 65355203 A US65355203 A US 65355203A US 2005174535 A1 US2005174535 A1 US 2005174535A1
Authority
US
United States
Prior art keywords
eye
patient
vision
light
wavefront
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/653,552
Inventor
Shui Lai
Andreas Dreher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ENTERPRISE PARTNERS VI LP
Original Assignee
Ophthonix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2003/004921 external-priority patent/WO2003068059A2/en
Priority to US10/653,552 priority Critical patent/US20050174535A1/en
Application filed by Ophthonix Inc filed Critical Ophthonix Inc
Assigned to KPCB HOLDINGS, INC., AS NOMINEE, C/O KLEINER PERKINS CAUFIELD & BYERS, ENTERPRISE PARTNERS VI, L.P., DIONIS TRUST reassignment KPCB HOLDINGS, INC., AS NOMINEE, C/O KLEINER PERKINS CAUFIELD & BYERS SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: OPHTHONIX, INC.
Assigned to OPHTHONIX, INC. reassignment OPHTHONIX, INC. RELEASE OF SECURITY AGREEMENT FILED ON DECEMBER 8, 2003. Assignors: DIONIS TRUST, ENTERPRISE PARTNERS VI, L.P., KPCB HOLDINGS, INC., AS NOMINEE, C/O KLEINER PERKINS CAUFIELD & BYERS
Assigned to OPHTHONIX, INC. reassignment OPHTHONIX, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: DREHER, ANDREAS W., LAI, SHUI T.
Publication of US20050174535A1 publication Critical patent/US20050174535A1/en
Assigned to ENTERPRISE PARTNERS VI, L.P. reassignment ENTERPRISE PARTNERS VI, L.P. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: OPHTHONIX, INC.
Assigned to OPHTHONIX, INC. reassignment OPHTHONIX, INC. RELEASE OF INTELLECTUAL PROPERTY Assignors: DIONIS TRUST, ENTERPRISE PARTNERS VI, L.P., KPCB HOLDINGS, INC., AS NOMINEE, C/O KLEINER PERKINS CAUFIELD & BYERS
Priority to US11/652,856 priority patent/US7490940B2/en
Assigned to COMERICA BANK reassignment COMERICA BANK SECURITY AGREEMENT Assignors: OPHTHONIX, INC.
Priority to US12/350,813 priority patent/US20090161070A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/10Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
    • A61B3/1015Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for wavefront analysis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/02Subjective types, i.e. testing apparatus requiring the active assistance of the patient
    • A61B3/028Subjective types, i.e. testing apparatus requiring the active assistance of the patient for testing visual acuity; for determination of refraction, e.g. phoropters
    • A61B3/032Devices for presenting test symbols or characters, e.g. test chart projectors

Definitions

  • the present invention relates generally to methods and apparatus for determining a person's visual characteristics, and more particularly to apparatus and methods for determining the refraction of the eye.
  • Phoropters are apparatus used by optometrists to determine a patient's visual characteristics, so that proper eye diagnoses can be made and eyewear can be prescribed.
  • a patient looks through the phoropter, in which various test lenses are disposed, at a target eye chart, referred to as a “Snellen chart,” while an optometrist moves the test corrective lenses into the patient's field of view.
  • the target may be positioned at a predetermined distance from the patient.
  • the patient is then asked to verbally compare the quality of the perceived image as afforded by one lens versus the prior lens presented.
  • the optometrist takes note of either an improvement or a deterioration in the patient's vision through such lenses.
  • the test progresses towards the “best” test lens entirely based on the patient's responses.
  • the lens parameters are then used as the basis for a prescription for eyewear.
  • the patient can become fatigued during the process and/or misjudge the vision afforded by the various lenses. This can lead to the selection of a less than optimum prescription.
  • some patients such as a very ill or a very young patient, might not be capable of articulating the quality of vision the various lenses afford the patient.
  • a retinoscopy method for example, a streak of light is projected to a patient's retina, and the characteristics of the reflected light at the patient's corneal plane is analyzed to determine whether the patient is myopic, or hyperopic, and with or without astigmatism.
  • the method does not provide sufficient accuracy for prescribing spectacle lenses. Consequently, its measurement results are typically used only as a starting point of a standard phoropter measurement.
  • autorefractor Another objective measurement instrument for determining refractive errors is an autorefractor, which, owing to its speed of use, is more popular than retinoscopy.
  • To use the autorefractor a patient is asked to look inside an enclosed box that is part of the autorefractor.
  • a target image is optically projected into patient's eye, and a series of lenses is automatically moved into position of the patient's line of sight to the target, to neutralize the patient's refractive errors (autorefraction).
  • autorefraction autorefraction
  • the measurement outcome often differs from the patient's ideal prescription. Accordingly, like retinoscopy, autorefractor outcomes typically are used only as starting points for standard phoropter measurements.
  • both retinoscopy and autorefraction fail to account for the accommodation effect of the patient, that is, for the propensity of a patient to alter his or her focus or sight to make the best of the vision test.
  • An autorefractor measurement essentially is a snapshot of the patient's vision at a particular instant at which the autorefractor has identified a so-called neutralization point, and at this point if it happens that the patient focuses his vision for seeing an image at a distance other than what is intended, or if the patient is momentarily looking elsewhere other than the target, the output of the autorefractor is erroneous.
  • Such deceptive focussing on the part of the patient can arise because the patient is conscious of the working distance inside the box, and when an image of an object presented to the patient which is modeled to be located at, e.g., twenty feet, the patient automatically focuses for an image at a much closer distance, knowing the actual size of the box. Examination results that include patient accommodation effects are inaccurate for prescribing spectacle lenses.
  • autorefractor Another limitation of the autorefractor is that the examiner has no control over which lens is to be used in the test. The result is that repeated measurements are likely to provide different results for the same eye from the same patient, which results in laborious and time consuming tests and retests when using the device to finalize a prescription.
  • One aspect of the invention comprises an apparatus for determining the refraction of a patient's eye focused on a physical target.
  • the apparatus comprises a light source and optics that direct light from the light source to the patient's eye. The light reflects from a surface of the eye. This reflected light comprises a plurality of wavefronts.
  • the apparatus further comprises a wavefront measurement device positioned along a first optical path to the eye to measure the shape of the wavefronts reflected from the patient's eye along this first optical path.
  • At least one test lens is disposed along a second optical path between the patient's eye and the physical target. The optics and the at least one test lens are arranged such that when the patient looks at the physical target through the test lens, the light from the light source is directed through the eye so as to determine the refraction from the wavefronts returning from the eye.
  • Another aspect of the invention comprises a method of quantifying the quality of a person's vision.
  • a test lens is provided through which the person views a physical target spaced from the test lens.
  • Light is directed into an eye of the person when the person looks through the test lens at the physical target. Some of the light reflects from tissue in the eye such that the light propagates through an ocular lens and cornea of the eye and exits the eye.
  • a wavefront of the reflected light emanating from the person's eye is measured.
  • One or more values of a figure of merit are determined using the wavefront measurement.
  • the figure of merit is indicative of quality of a person's vision.
  • a graphic based on the one or more values of the figure of merit is produced. This graphic is indicative of the quality of a person's vision.
  • Yet another aspect of the invention comprises a method of characterizing a person's vision.
  • corrective optics are provided for testing the vision.
  • the corrective optics are variable to provide different amounts of optical correction for reducing optical aberration.
  • a light beam is directed into an eye of the person. Light from this light beam reflects from tissue in the eye such that the light propagates through an ocular lens and cornea of the eye and exits the eye.
  • the reflected light comprises a plurality of wavefronts.
  • the wavefronts emanating from the person's eye are repetitively measured with the corrective optics adjusted to a substantially fixed amount of optical correction.
  • a set of data points indicative of the quality of vision of the person for a given amount of optical correction are thereby produced. The average and variation in the plurality of data points are determined to provide an objective assessment of the correction.
  • the corrective optics may be altered to provide different amounts of optical correction.
  • the reflected light from the person's eye is repeatedly measured for each of the different amounts of optical correction, thereby yielding a set of data points for the different amounts of optical correction.
  • the average and variation in the plurality of data points is determined for the different amounts of optical correction.
  • Another aspect of the invention comprises an apparatus for automatically determining correction for a patient's vision.
  • This apparatus includes test optics for testing the vision, the test optics are variable to provide different amounts of optical correction.
  • the apparatus further includes a light source and associated optics for directing light into an eye of the patient. The light from the light source reflects from tissue in the eye. This reflected light comprises a plurality of wavefronts that propagate through an ocular lens and cornea in the eye.
  • a wavefront sensor that comprises one or more optical detectors for measuring the wavefronts emanating from the patient's eye is included in the apparatus.
  • the wavefront sensors has an electrical output representative of the wavefront.
  • An electrical processor is configured to receive the electrical output from the wavefront sensor and determine the quality of the patient's vision therefrom.
  • a mechanical actuator is electrically connected to the processor. The mechanical actuator adjusts the test optics so as to vary the amounts of optical correction.
  • Still another aspect of the invention comprises a method of determining correction for a person's vision.
  • light is directed into an eye of the person.
  • the light reflects from tissue in the eye.
  • This reflected light comprises a plurality of wavefronts that propagates through an ocular lens and cornea in the eye.
  • the wavefronts are measured with a wavefront sensor.
  • At least one of the wavefronts is represented by a series of orthogonal components, ⁇ K n Q n , where Q n corresponds to the orthogonal components and K n corresponds to coefficients having values selected to substantially match the sum with the wavefront.
  • the orthogonal components are weighted with psychometric weight factors P n based on their relative influence on human vision.
  • Optical correction is designed based on the wavefront representation and the psychometric weight factors.
  • Another aspect of the invention comprises a method of quantifying accommodation in an eye having a cornea, an ocular lens, and a retina.
  • a light beam is directed into the eye.
  • Light from the light beam is reflected from tissue in the eye such that the light propagates through the ocular lens and cornea of the eye and exits the eye.
  • Wavefronts associated with the reflected light emanating from the eye are repetitively measured for a set of conditions that induce an amount of accommodation.
  • a set of data points indicative of the quality of vision for the plurality of wavefronts measured under this set of conditions are thereby produced.
  • the average and variation in the plurality of data points are determined to provide a measurement of the amount of accommodation.
  • the reflected light from the eye is repetitively measured for another set of conditions that induce a different amount of accommodation thereby yielding an additional set of data points for this different amount of accommodation.
  • the variation in the plurality of data points is determined to provide a measurement of this different amount of accommodation.
  • Yet another aspect of the invention comprises a computer readable medium having a program of instructions stored thereon for causing an electrical processor to execute method steps for identifying optical correction for a person's eye based on wavefront measurements of light reflected from said person's eye. These method steps comprise:
  • Yet another aspect of the invention comprises a phoropter that includes plural test lenses that can be disposed into a line of sight defined between a patient and a target, such that a patient looking at the target perceives light from the lens.
  • a wavefront measurement apparatus is positioned to detect aberrations in light returning from the patient. These aberrations are caused by the eye of the patient.
  • the phoropter may further comprise a processor that outputs a diagnostic signal that corresponds to an objective assessment of the patient's quality of vision.
  • the processor may be in communication with a display device for generating at least one visual display representative of an effectiveness of a test lens in correcting the patient's vision.
  • the processor may employ the objective assessment of the patient's quality of vision to select a next test lens to determine a successive objective measurement of the quality of vision corresponding to the next test lens.
  • the processor may determine the standard deviation of the objective measurement of the patient's quality of vision and one or more successive objective measurements of the quality of vision for different test lenses and identify a substantially optimal vision correction lens for the patient.
  • the objective assessment of the patient's quality of vision may also be useful for generating an image representation of the target.
  • a wavefront measurement apparatus includes a light source, such as a laser or light emitting diode (LED), for generating the light and a light detector that outputs a signal representative of the aberrations. Also, the apparatus includes a processor that receives the signal from the light detector and outputs a diagnostic signal representative thereof. The diagnostic signal is° useful for generating an image representative of the test object, and/or for generating at least one visual display representative of an effectiveness of the lens in correcting a patient's vision.
  • the visual display can include a bar chart, a pie chart, and/or a line chart, and it can be color coded.
  • the display may include, for example, (1) an image generated by a convolution of the image of the test object based on the wavefront returning from the patient's eye and through the lens, (2) a numerical and/or graphic display representative of the effectiveness of the lens, or (3) a numerical and/or graphic display of the contrast function of the patient's vision.
  • a method for indicating the quality of a patient's vision includes providing a device through which a patient can look at a target. The method also includes directing a laser beam into the eye of the patient when the patient looks at the target, and then detecting aberrations in a wavefront of the light beam as the light beam returns from the patient's eye. Based on the wavefront, the method indicates a quality of a patient's vision. In various preferred embodiments the refraction for the patient is determined.
  • this method may further include prescribing ophthalmic lenses for the patient.
  • Ophthalmic lenses for correcting refractive errors of the patient may be prescribed and/or dispensed that are designed to reduce or correct (i) the low order aberrations including sphere, cylinder, and axis, or (ii) low order aberration in (i) and higher order aberrations including the third order and possibly higher Zernike terms.
  • a method for indicating the quality of a patient's vision includes providing a device into which a patient can look, and that generates a substantially instantaneous visual indication of a quality of a patient's vision.
  • the method may further include indicating the quality of a patient's vision by using at least one visual display representative of the effectiveness of a first lens in correcting the patient's vision.
  • the display representing the effectiveness of the first lens may be evaluated and a second test lens may be selected.
  • the second test lens may be positioned in the patient's line of sight and at least a second visual display representative of an effectiveness of the second test lens in correcting the patient's vision may be generated.
  • Selecting the second test lens may include determining at least one of (a) the onset of the patient's accommodation, and (b) the range of the patient's accommodation. Fogging may be employed to select a more suitable lens for the patient.
  • a device for aiding a practitioner in knowing the integrated effect of a patient's eye and a test lens placed in front of the eye includes means for sensing an optical wavefront returning from the eye through the lens. Means are coupled to the wavefront sensing means for generating an indication of the integrated effect of the eye and the test lens.
  • a device for generating an indication of the quality of vision of a patient viewing a target includes a light beam generator directing light into the eye of the patient, and a wavefront sensing device detecting an optical wavefront returned from the eye of the patient while the patient is looking at the target.
  • a computing device receives input from the wavefront sensing device that is representative of the wavefront.
  • the computing device outputs a substantially continuous update of at least one of: a point spread function (PSF) and a modulation transfer function (MTF), while the patient is looking at the target.
  • PSF point spread function
  • MTF modulation transfer function
  • a display device displays at least one of: a simulated image of the target at the patient's retina, a quality of vision indicator indicating the quality of vision, and a graph indicating a contrast function of the patient, based at least in part on at least one of the point spread function and the modulation transfer function.
  • a vision quantifying device in yet another aspect, includes a beamsplitter through which a patient can look at a target.
  • a source of light emits light into an eye of the patient, which reflects from the eye as a return beam.
  • a processor receives a signal representative of a wavefront of the return beam and generates at least one signal in response thereto, and a display receives the signal and presents a visual indication of the patient's sight.
  • Another aspect of the invention is to provide automatic refraction correction.
  • the patient looks at a target.
  • a test lens is positioned between the target and the patient's eye, and in the line of sight of the patient.
  • a light beam is directed through the test lens and into the patient's eye.
  • a wavefront profile is reconstructed.
  • a quality vision factor (“QVF”) may be calculated.
  • QVF quality vision factor
  • a number of measurements of the returning wavefront profile are taken, and the corresponding QVF values for each of the measurements for that particular test lens, is analyzed. The analysis of this data provides for a determination that the correction with that particular lens is optimal.
  • FIG. 1 is a perspective view of one embodiment of an apparatus for characterizing a patient's vision, in one intended environment;
  • FIG. 2 is a perspective view of the apparatus, showing the patient
  • FIG. 3 is a block diagram of the components of one preferred apparatus
  • FIG. 4 is a flow chart of the some preferred logic
  • FIGS. 5-9 are exemplary non-limiting diagrams of quality of vision displays.
  • FIG. 10 is a flow chart showing an automatic refraction method described herein.
  • an exemplary apparatus is shown, generally designated 10 , and includes a housing 12 that can be mounted on a movable stand 14 for positioning the housing 12 in front of a patient 15 who might sit in an examination chair 16 .
  • the patient 15 can position his or her head against the housing 12 .
  • the housing 12 can be supported on the head of the patient 15 and/or be suspended from a flexible overhanging arm which may be attached to a stand, to provide weight balance and to facilitate mounting and dismounting of the head mounted-apparatus.
  • the apparatus can be co-mounted with a conventional phoropter (not shown), in which case the test lenses, described more fully below, can be established by the lenses of the conventional phoropter.
  • Other configurations may also be practicable.
  • the patient 15 can look through the housing 12 to a target 18 , such as but not limited to a Snellen chart.
  • the target 18 can be positioned at any appropriate distance from the patient 15 , e.g., twenty feet or closer.
  • the target 18 is a distance z o of about 8 to 20 feet from the patient's eye 15 . Since the target 18 can be positioned at a distance that actually is the distance intended, the above-noted patient accommodation effects related to autorefractors, are reduced or eliminated.
  • a mirror may be inserted in the optical path between the system 10 and the target 18 to introduce a turn in the optical path. These reflectors may be employed, for example, to accommodate suitable placement of the target 18 such as on the ceiling of an office where the vision tests are being administered.
  • FIG. 3 shows one exemplary implementation of the housing 12 . While FIG. 3 shows that various components are located inside the housing 12 and various other components such as the output display are located outside the housing 12 , it is to be understood that the principles advanced herein apply to systems having multiple housings, or a single housing. Additionally, other component and configurations may be included in the design.
  • the patient looks at the target 18 through a transparent window within the housing 12 , such as can be established by a primary beamsplitter 20 or other optical element.
  • movable is meant physically movable by hand or computer or electronically-controlled mechanism as indicated as “M” in FIG. 3 , and more fully disclosed below, such that the lens is selectively interposed in or out of the line of sight of the patient 15 .
  • the test lens may also be movable in the sense that a variable focal length lens can be used, with its optical characteristics being variable in accordance with principles known in the art, for example those utilized in various designs of autorefractors.
  • the test lens 22 can be, but should not be limited to, a single concave convex lens, or a combination of optical components such as lenses, and may include a cylindrical lens and a prism.
  • the test lens 22 may be disposed in an optical path between the primary beamspiitter 20 and the patient's eye 15 as depicted in FIG. 3 .
  • the distance y o between the test lens 22 and the eye is relatively small, compared, for example, to the distance to the target 18 .
  • the separation between the eye 15 and the lens 22 may, e.g., be between about 0.8 and 1.6 centimeters in some embodiments. In the case, where this separation is small, the distance from the test lens 22 to the physical target, z o ⁇ y 0 , is approximately equal to the distance z o from the eye to the target 18 .
  • a light source such as but not limited to a laser 24 generates a light beam 26 that can be directed, in one preferred embodiment, toward a laser beamsplitter 28 .
  • the laser beamsplitter 28 reflects the light beam 26 toward the primary beamsplitter 20 , which in turn reflects the beam through the test lens 22 and onto the eye of the patient.
  • the test lens 22 may be inserted in the optical path between the beamsplitter 20 and the target such that the laser beam 26 does not pass therethrough.
  • the vision is at least partially corrected. Measurements may be more accurate when vision is good and the eye is not stressed and is operating more normally.
  • the beam 26 is reflected therefrom, back through the lens 22 , and is reflected off the primary beamsplitter 20 .
  • the beam passes through the laser beamsplitter 28 , and a portion of the beam is reflected off a pupil detection beamsplitter 30 toward a pupil light detector 32 through one or more focussing lenses 33 , for purposes to be shortly disclosed.
  • a portion of the return beam passes through the pupil detection beamsplitter 30 and propagates through an optical relay unit 34 , which focuses the beam onto a wavefront analyzer optics 36 .
  • the wavefront analyzer optics 36 generates a signal representative of the wavefront of the return beam, and a wavefront detector 38 transforms the signal into an electrical signal for analysis by a processor 40 .
  • the processor 40 can be associated with control electronics known in the art for undertaking control of one or more components (e.g., the light source 24 ) of the system 10 as more fully set forth below.
  • the processor 40 can generate the below-described visual indications of the patient's vision as corrected by the test lens 22 and can cause the indications to be displayed on a display device 42 , such as a video monitor, that can be mounted on the housing 12 or apart therefrom.
  • the display device 42 can be a liquid crystal display that can be mounted on the housing 12 of the system 10 , or a stand-alone display unit conveniently located for the examiner's viewing. Suitable displays may include, but not be limited to, numerical and/or graphical representations indicative of the patient's quality of vision, as described more fully below.
  • an illumination light 44 e.g., a ring-shaped fiber optic
  • the illumination light 44 can be a source of diffused light.
  • the light intensity of the illumination light 44 may be controlled by the processor 40 in response to feedback from the pupil light detector 32 , which can comprise, e.g., a CCD camera, or reticon detector array to monitor the size of the pupil, so that a predetermined pupil size can be maintained for the patient during the measurement.
  • the locations of the pupil detection unit, including the components, beamsplitter 30 , lens 33 , and pupil light detector 32 can be in other appropriate locations along the optical path of the return light from the eye, including locations inside the optical relay unit 34 .
  • the system also monitors the first Purkinge image, an image formed by reflection at the anterior surface of the cornea of the light beam 26 .
  • the position of this image relative to the pupil boundary is an indication of gazing direction of the patient under examination.
  • the relative position of the First Perkinge image is a well defined bright spot, and it is typically inside the pupil boundary. Therefore, in a preferred but non-limiting embodiment, the pupil detector 32 can also function as a patient gazing monitor.
  • the relative position of the First Perkinge image to the pupil is determined by processing of the image data from the CCD camera, for example, using data filtering, contrast enhancement, and pupil boundary determination methods known in the art.
  • software processing can be done in real time in a matter of a fraction of a second.
  • the objective of this analysis is to determine whether the patient is looking at the target, or momentarily drifting off.
  • the information is electromagnetically transmitted to the central control unit 40 . If the patient is not looking at the target, the data set from the wavefront detector unit 38 is rejected, and preferably is not displayed or accumulated for data analysis.
  • the light source 24 can be a diode laser that emits light at near infrared wavelengths.
  • the light detectors 32 , 38 can be implemented by CCD arrays or linear reticon arrays or other detection devices.
  • the primary beamsplitter 20 can be coated to transmit visible light and to reflect infrared light.
  • the laser beamsplitter 28 can be a polarization dependent reflector, in which case the laser light is polarized, and a quarter wave plate (not shown) is disposed in the beam path to the patient 15 such that the return beam is rotated ninety degrees (90°) upon double passing the quarter wave plate for facilitating passage thereof through the laser beamsplitter 28 toward the wavefront analyzer optics 36 .
  • the laser beamsplitter 28 can be plate coated for high transmission and low reflectivity at forty five degrees (45°) incident angle, such that only a small portion of the laser light is reflected into the eye, but a high percentage of the return light propagates through the laser beamsplitter 28 .
  • the optical relay unit 34 can include two convex lenses F 1 and F 2 that together establish a telescope.
  • the lenses F 1 , F 2 are separated from each other by a distance equal to the sum of their focal lengths, with the focal plane of the first lens F 1 being located at the front surface of the test lens 22 , i.e., the surface facing the primary beamsplitter 20 .
  • the focal plane of the first lens F 1 is preferably located at the front of the eye, i.e. the front of the cornea.
  • the focal plane of the second lens F 2 is located at the image plane of the wavefront analyzer optics 36 .
  • the purpose of the telescope structure of the relay unit 34 is to relay the wavefront at the exit surface of the test lens 22 to the image plane of the wavefront analyzer optics 36 .
  • Alternative relay optics can be used to achieve the same or different purpose.
  • the optics 36 can include an array of lenslets arranged as in a Shack-Hartmann wavefront sensor, an example of which can be found in page 37, “Customized Corneal Ablation The Quest for Super Vision” edited by MacRae, et. al. published by Slack Incorporated, 2001, incorporated herein by reference.
  • Shack-Hartmann wavefront sensors and processors are available, for example, from commercial vendors such as Wavefront Sciences, in Albuquerque, N. Mex., Zeiss/Humphrey Instruments, in Dublin, Calif., or Bausch and Lomb, in Irvine, Calif.
  • the optics 36 can include ruled reticles such as those disclosed in co-pending application U.S. patent application Ser. No. 10/014,037, entitled “SYSTEM AND METHOD FOR WAVEFRONT MEASUREMENT”, filed Dec. 10, 2001, and U.S. patent application Ser. No. 10/314,906, entitled “SYSTEMS AND METHODS FOR WAVEFRONT MEASUREMENT”, filed Dec. 9, 2002, both of which are incorporated herein by reference, which use a self-imaging diffraction principle to detect the wavefront in the return beam.
  • the processor 40 analyzes the profile of the wavefront of the light returned from the patient's eye, and quantifies the wavefront aberrations in two regimes: low order aberrations, including spherical refractive error, cylinder, and axis, and higher order aberrations, including coma, spherical aberrations and other higher order terms that can be described by Zernike polynomials. Quantitative data representing the patient's quality of vision are then graphically presented on the display device 42 .
  • FIG. 4 an exemplary mode of operation of an apparatus such as depicted in FIG. 3 can be seen.
  • the patient 15 views the target 18 through the system 10 , and in particular through the transparent window that is established by the primary beamsplitter 20 .
  • the examiner initiates the vision test by inserting a selected test lens 22 in the line of sight of the patient, or by configuring a variable focal length lens 22 to have a predetermined focal length. Inserting means either manual positioning or positioning using a motor or other translation or rotation mechanism.
  • the processor 40 can select a particular lens 22 and cause it to be automatically moved in the line of sight, in accordance with discussion below.
  • FIG. 4 Various steps represented by blocks in FIG. 4 involve calculations, and other types of activities that can be automated and at least partially implemented using for example computer logic.
  • processes and methods described and shown herein include, but are not limited to, those depicted in at least some of the blocks in the flow chart of FIG. 4 as well as the flow chart in FIG. 10 , which is described more fully below.
  • These and other representations of the methods and processes described herein illustrate the structure of the logic of various embodiments of the present invention which may be embodied in computer program software.
  • the flow charts and description included herein illustrate the structures of logic elements, such as computer program code elements or electronic logic circuits.
  • various embodiments include a machine component that renders the logic elements in a form that instructs a digital processing apparatus (that is, a computer, controller, processor, etc.) to perform a sequence of function steps corresponding to those shown.
  • a digital processing apparatus that is, a computer, controller, processor, etc.
  • the logic may be embodied by a computer program that is executed by the processor 40 as a series of computer- or control element-executable instructions. These instructions may reside, for example, in RAM or on a hard drive or optical drive, or the instructions may be stored on magnetic tape, electronic read-only memory, or other appropriate data storage device.
  • the processor 40 determines the point spread function (PSF) that is derived from using, for instance, the terms of Zernike polynomials, which is in turn derived from the wavefront passing through the wavefront analyzer optics 36 and transformed into an electrical signal by the wavefront detector 38 when the wavefront data is acquired.
  • G ( X img , Y img ) ⁇ PSF ( x ⁇ x img ,y ⁇ img ) f ( x img ,y img ) dxdy, wherein f( x img , y img ) is the test target 18 ( FIG.
  • x img ⁇ x img is the difference in the x-dimension between each point in the PSF and the corresponding ideal point in the ideal image
  • y ⁇ y img is the difference in the y-dimension between each point in the PSF and the corresponding ideal point in the ideal image
  • the convolutional function G can be used at output state 52 to generate an appropriately blurred image, point by point, of an ideal image as affected by the imperfection of the patient's eye in combination with the lens 22 .
  • the ideal image function can be the letter “E” or a series of other letters, e.g., of various physical sizes as conventionally used in the various lines in the Snellen chart.
  • FIG. 5 shows one such blurred image at 54 , which can be presented on the display 42 .
  • the target can be a picture, and the convolved image G(x img , y img ) Of the picture is blurred point by point, according to the PSF, which represents an image of the target formed at the patient's retina.
  • the letters in the simulated blurred image have the same blurring as perceived by the patient 15 .
  • the examiner can visualize the clarity and sharpness of the image as a result of the lens 22 as it is perceived by the patient 15 .
  • the processor 40 can generate the displays shown in FIGS. 6-8 as follows.
  • the wavefront profile as indicated by the above-mentioned linear combination of Zernike polynomials, is filtered to eliminate terms with coefficient below a threshold amplitude.
  • a psychometric weighting factor “P” is inserted for each of the remaining Zernike terms as shown in the following. This weighting factor “P” represents the effect of the brain to discriminate objects despite certain types of ocular aberrations. For example, most people can discern a letter in a Snellen chart with a certain amount of defocus while the same amplitude of aberration in coma would not allow the same patient to discern that letter.
  • QVF Quality of Vision Factor
  • the psychometric weighting factors “P n ” can be determined by presenting a particular aberration to a normative group of people representing an average population distribution, for example, between about two hundred to several thousand people, depending on the accuracy level desired and the range of the scatter value of each type of aberration measurement.
  • the patients are presented one at a time with particular types of aberrations selected from the Zernike polynomials, and then the patients are scored for the extent of success in discerning the target, for example, by the number of letters correctly read on the Snellen chart, or other standardized vision test chart.
  • Other methods based on contrast level, standardized letter size, sine or square wave patterns can also be used. For example, success of patients in discerning graphics consisting of lines having various cycles per degree may be employed to test contrast sensitivity.
  • the optical element for introducing such aberration can be an aberration plate on which a selected type of aberration has been imprinted.
  • the aberration type can be a coma, or a trefoil, having a refractive index profile to produce the proper phase changes as specified by the corresponding Zernike polynomial.
  • one or more of the displays shown in FIGS. 6-8 can be generated and displayed as indicated in block 60 .
  • a bar chart display can be generated to present an overall indication of the patient's quality of vision as afforded by the lens 22 under test.
  • the indicator can be in the form of a graduated bar 62 , the height of which is proportional to the QVF determined at block 60 , with zero indicating poor vision and perfect vision being indicated by a bar extending from the bottom to the top 64 of the scale.
  • the display scale can be a log scale, in which case the “best” is indicated by the bar 62 being at zero, and rising logarithmetrically with worse vision using a root-mean-square function of the QVF.
  • Enhancements to the bar 62 such as color-coding can be used.
  • the bar 62 can be colored red for poor vision and green for good vision, with other colors being used to indicate intermediate qualities of vision.
  • the QVF can be used to generate a pie chart as shown in FIG. 7 , with the size of a pie slice 66 relative to the entire circle being linearly or logarithmetrically proportional to the QVF.
  • the system 10 can substantially continuously measure the wavefront profile of the light beam returned from the patient's eye. Accordingly, in one preferred, non-limiting embodiment, a sequence of QVF measurements (e.g., twenty) for a single test lens 22 can be made in a second or two and grouped together.
  • the measurement accuracy can be improved by monitoring the gazing direction of the patient, and the computing device in block 40 can reject the data points acquired when the patient was not looking at the designated target. Furthermore, the computing device can also accumulate data and perform calculations for average values and standard deviation for selected subsets of measurement.
  • FIG. 8 shows a resulting display.
  • five lenses 22 have been tested and several QVF values obtained over a short period for each.
  • Each group of QVF values is plotted as a respective vertical line 68 on a plot of QVF versus lens, with the length of each error bar line 68 representing the standard deviation of the measurements for that particular lens and the center of each line representing the mean QVF value.
  • the prescription can be based not only on a high mean QVF value, as indicated at points 70 and 72 , but also on a small standard deviation, as indicated by bar 74 .
  • the lens corresponding to the bar 74 might be selected because its QVF values had a small standard deviation from each other and it had a high mean QVF value, even if not as high as the point 70 .
  • An example case is a patient who has not had a vision check for an extended period of time and requires correction of more than 1.5 diopters in cylinder.
  • embodiments of the present invention may provide objective data based on the subjective response of the patient to a test lens set 22 presented to the patient.
  • Determining the variation in the figure of merit preferably involves performing multiple measurements with consecutive measurements separated by a sufficiently long time interval.
  • This time interval is preferably long enough to permit the eye to adjust its focus.
  • the variation in data points should reflect adjustments made by the eye such as are present when the eye is straining to focus or accommodate.
  • the time period between consecutive measurements is therefore preferably between about 0.1 to 5 seconds, however, values outside this range are also possible.
  • various test conditions may be presented to the patient under examination to investigate the subjective responses to such conditions.
  • objective measurements are performed to determine the subjective response of the patient to different optical correction.
  • a prescription for correction of the refractive errors that is superior to that obtained with conventional objective measurement approaches is possible.
  • Other conditions can be altered and the subjective response of the patient determined using the objective measurements described herein. Fogging and testing for the range of the accommodative ability are some other examples of how conditions that affect vision may be controlled and tested.
  • the apparatus and methods described herein advantageously can enables quantification of the subjective response of the patient by performing objective measurements, i.e., without any verbal communication with the patient.
  • the patient can be presented with a series of standardized patterns of sine wave gratings of increasing spatial frequency frequencies, with the patient offering subjective responses.
  • the resulting examination report can be a curve that depicts a cutoff contrast intensity at various spatial frequencies.
  • Embodiments of the present invention can provide a quantitative evaluation of a patient's ability to handle contrast, which can be generated in addition to or in lieu of those displays discussed above.
  • Such a display can be generated at output state 76 in FIG. 4 and is shown in FIG. 9 , showing a curve 78 depicting actual patient optical contrast function (OCF) and a reference curve 80 depicting a diffraction-limited reference.
  • OCF optical contrast function
  • OCF MTF ⁇ M iat.
  • MTF the modulation transfer function determined at block 48
  • M iat is a mathematical function accounting for the low frequency filtering of the neural system, the value of which linearly increases with spatial frequencies with a slope of unity in a log-log scale plot and reaches the maximum value of one at and above the spatial frequency of seven cycles per degree.
  • the OCF does not include the effect of the brain processing at frequencies higher than seven cycles per degree, but it does provide valuable information about the patient's ability to discern sine gratings of various spatial low frequencies based on a patient's optics.
  • the above process of measuring (and displaying) indications of the improvement in vision afforded by a particular test lens 22 to the patient 15 can be continued at block 82 until the “best” test lens is found.
  • This can be done by the examiner manually swapping lenses 22 as, e.g., in a conventional phoropter.
  • the positioning of test lenses 22 can be done automatically by the processor 40 controlling the moving mechanism “M”, which can include a motor (or actuator) and coupling structure connecting the motor/actuator to one or more lenses 22 .
  • the mechanism follows an instruction from the processor 40 to insert the particular lens in the line of sight of the patient, as requested by the processor.
  • the sequence of test lenses 22 to be used in an examination may be programmed into the processor 40 in accordance with examination strategy and routines known in the art.
  • the starting lens can be selected based on the patient's current spectacle prescription or based on the wavefront measurement without any test lens 22 in the patient's line of sight. Consequently, in reconstructing the return beam wavefront without a test lens 22 being in the beam path, the processor 40 essentially models the uncorrected aberrations of the patient's eye in Zernike terms.
  • the processor 40 can determine the equivalent diopter power in sphere and cylinder and its axis, and select the appropriate lens 22 being used to start the examination. In selecting test lenses 22 , the processor 40 can use the above-disclosed QVF values or other figures of merit in lieu of subjective responses from the patient, and can then execute the examination strategy as if it is performed with the subjective response from the patient.
  • Process 100 begins with a first step 102 wherein the patient looks at a target.
  • a test lens is positioned between the target and the patient's eye, and in the line of sight of the patient.
  • a light beam is directed through the test lens and into the patient's eye in step 106 .
  • the test lens may be positioned outside of the light beam, yet in the line of sight of the patient, positioned between the beam splitter 20 and the target 18 in FIG. 3 .
  • the patient's vision is affected by the test lens as he is looking at the target, but the wavefront emerging from the patient's eye is directed to the wavefront sensor without passing through the test lens, and thus this wavefront contains both the low order and higher order aberrations of the patient's eye.
  • step 108 the light returning from the patient's eye is detected. From this detected light, the wavefront profile may be reconstructed, as shown in step 110 . From the reconstructed wavefront profile, the quality vision factor (“QVF”) may be calculated in step 112 .
  • QVF quality vision factor
  • N number of measurements are performed using the returning light. Accordingly, “N” wavefront measurements are taken, thereby yielding N wavefront profiles and corresponding QVF values. These successive measurements are taken by returning from step 112 to step 108 , in which the returning light is again detected.
  • Steps 108 through 112 are executed “N” times for the test lens. As described above, the “N” measurements are spaced apart in time by a sufficient amount to allow the patient to adjust their focus. For example, this time interval is preferably long enough to permit the muscles in the eye to readjust.
  • the QVF for that particular test lens is analyzed in step 114 .
  • the analysis of this data provides for a determination whether the correction with that particular lens is optimal. This decision is made in step 116 , and if the correction is not optimal, a next test lens is selected in step 120 , and the process returns to step 104 where the next test lens is positioned in the patient's line of sight. On the other hand, if the correction with that particular lens is optimal, then the process ends in step 122 resulting in the proper refractive correction having been identified.
  • the optimal lens may not be identified immediately after that particular lens is tested on the patient. Instead, the suitable lens may be selected after trying one or more additional test lens. Such is the case wherein a figure of merit analysis like that illustrated in FIG. 8 is employed.
  • a series of lenses in 1 ⁇ 4 diopters increments are used to determine the patient's optical correction.
  • the diopter increments can be in 1 ⁇ 8 instead of 1 ⁇ 4, depending upon the magnitude of correction necessary.
  • a number (“N”) of measurements of the returning light are performed in steps 108 through 112 to calculate the QVF for the particular test lens.
  • 5-20 separate measurements i.e., “N” equals 5-20
  • more or less measurements may be performed depending upon the particular wavefront sensor device used, and the magnitude of correction necessary.
  • the prescription can be determined by a person viewing the display, e.g., of FIG. 8 , or automatically by the processor 40 based on a high QVF value and low standard deviation, as follows:
  • the examiner, or the processor 40 will examine the curve shown in FIG. 8 , which connects the average values of the QVF's for various lens sets presented to the patient.
  • Certain embodiments may include the step of performing a best fit to the average values, using a polynomial of up to 4 orders, for example.
  • the processor 40 searches for the maximum value, of the “peak” of the curve. This can be accomplished by monitoring the peak value of the curve, or the slope of the curve, e.g., from decreasing lens power, from right to left, in FIG. 8 . When the curve reaches its maximum value, the slope changes sign, and the maximum is at the zero slope value. Now, the processor 40 sends the peak value of the QVF and the corresponding lens power to the display or a printer.
  • the processor 40 may also search for the minimum value among the standard deviation in the data set such as shown in FIG. 8 .
  • a figure (not shown) similar to FIG. 8 showing standard deviations versus lens power can be useful in determining the minimum value. Again curve fitting can be employed.
  • the minimum value may be identified for example by detecting the sign change in the slope as described above for determining the maximum QVF value. Again, this minimum standard deviation value and the corresponding lens power are sent to the display device or a printer for record. For example, on the display or the printout the processor may indicate that lens power with the maximum QVF value provides for the sharpest image, while the lens power with the minimum standard deviation provides for the most comfortable prescription to the patient.
  • both the average value of the figure of merit and its variation may be employed together to determine the suitable correction.
  • the optical correction selected may for example be substantially equal to an amount between the optical correction yielding the least variation and the optical correction yielding the least aberration.
  • FIG. 3 illustrates a system 10 wherein the return beam from the lens 22 is detected and analyzed and, hence, the integrated effect on the wavefront introduced by the eye and lens 22 is measured
  • the test lens 22 may for example be located between the primary beamsplitter 20 and the target 18 .
  • the effect of the lens 22 which has a known deviation from spherical, can be accounted for by adding or subtracting the lens 22 effect as appropriate from the eye-only wavefront.
  • a sensor (not shown) can be provided that senses which lens 22 is moved into the patient's line of sight. The sensor sends a signal representative of the lens 22 (and, hence, of the optical contribution of the lens) to the processor 40 .
  • the examiner can use conventional tactics in the steps of selecting test lenses 22 as if the whole process were done using a conventional phoropter that requires subjective responses from the patient.
  • the examiner can use “fogging” in accordance with principles known in the art to form an artificial image before the retina of the patient to cause the patient to relax the above-mentioned accommodative power.
  • the examiner can identify the test lens 22 with which the patient achieves good vision without accommodation, regardless of patient verbal cooperation or ability to judge and articulate which lens 22 is preferable.
  • the variation in the vision figure of merit may be determined for a variety of conditions that may induce differing amounts of accommodation. These conditions may include, for instance, distances from the eye to the target. Additionally, these conditions may include different amounts of optical power in the case wherein optics are inserted in the optical path between the eye and the target.
  • the eye may accommodate. This accommodation may be characterized, for example, by determining the average value of the N measurements and the variation in the figure of merit values with varying condition and its corresponding accommodation response of the patient.
  • the examiner may observe the displays and continue to decrease the focusing power (or increase minus power) of the test lenses being used, thereby moving the image behind the patient's retina.
  • the patient's accommodative power may be in the range of 1 to 5 diopters, with younger patients tending to have greater accommodative power.
  • determining the onset of accommodation is typically an important task to avoid an over minus corrective power in prescribing spectacle lenses.
  • the examiner may find both the accommodative onset and the range of accommodation. The examiner may start with a higher corrective power lens than what is optimal for the patient that causes the image of the target to fall in front of the retina.
  • the approximate optimal power may be determined from an autorefractor measurement, or measured directly from the patient's spectacle lenses.
  • the starting power for the test lens is then preferably chosen to be 1 to 3 diopters higher than the approximate optimal power.
  • the quality of vision and the figure of merit value is below the optimal value at this point.
  • the examiner may decrease the corrective power of the test lens, thereby bringing the target into sharper focus, and an improved figure of merit of vision which is also shown by the increase of the average value of the figure of merit. This continues until a peak average value of the figure of merit is reached. This peak value is noted as the actual optimal refractive correction for the patient. So far, the examiner has performed a process that in many respects is similar to a traditional fogging, except that the entire procedure is done using a objective method and no verbal communication is needed.
  • any further decrease of the refractive power of the test lens would cause the figure of merit value to drop.
  • accommodation would be applied to cancel the over minus effect of the test lens, so that the patient's focusing effort results in a sharp image of the target.
  • the average value of the figure of merit does not drop appreciably at this point, but only slightly and leveling to form a plateau.
  • the over minus power exceeds the accommodative range of the patient, the figure of merit value curve starts to drop.
  • the width of the plateau is an indication of the patient's range of accommodative power.
  • One aspect of this method is that while the patient may be able to see the target with reasonable sharpness using his accommodation, the extra efforts to drive the accommodation causes the focusing power of the eye to be unstable, which is manifested in the variation of the figure of merit value, or more specifically from the standard deviation calculation based on the number of repeated measurements.
  • the error bars representing the standard deviation if plotted over the average value curve as a function of the diopter power of the test lenses, similar to the one shown in FIG. 8 would typically show larger standard deviations with more efforts to accomplish focusing when looking through the over minus power lenses (curve not shown).
  • a young hyperopic patient who has not had his eye properly corrected, he may be conditioned to accommodate and often times the patient actually prefers to accommodate while looking at distant objects.
  • the standard deviation error bar may be smaller than at the zero accommodation point where the curve first reaches its maximum value.
  • a prescription may, for example, be chosen to be a mid point between the zero accommodation point and the point with the minimum standard deviation.
  • N may be in the range of, e.g., 3 to 10, are manifesting the subjective response of the patient as he reacts to various test lenses or other stimuli. Therefore, the aspect of using the average and the deviation of a figure of merit of vision has the ability of detecting subjective responses by studying the variation of the figure of merit over repeated measurements of the same test lens while the entire measurement is performed in an objective manner. The examiner can thereby determine the range of accommodation of the patient based on the objective measurements provided by the apparatus 10 and also provide a prescription to reduce accommodation or hyperopia errors.
  • repetitive measurements used in determining optical correction, accommodation, or other vision properties are spaced apart over time intervals that are sufficiently long to allow the person under examination to adjust the focus of their eye. Consequently, the information gathered by the system represents the physical response of the person to the various conditions to which they are exposed.
  • objective measurements can be obtained of the subjective responses of the patient without communicating with the person verbally, which is required when performing a manifest refraction using a conventional phoropter.
  • conditions that may be modified to characterize a person vision may include but are not limited to variations in test optics that are positioned in the line of sight as well as changes in the target distance.
  • the target distance can be modified by moving the physical target.
  • the apparent distance of the target can be changed by manipulating the beam of light from the target to the eye.
  • the apparent distance of the target can be controlled by altering the beam of light from the target to the eye.
  • the patient's eye collects a portion of the light emanating from the target.
  • the divergence angle of these collected rays will depend on the location of the target. For example, as is well known, light from a point object at the infinity is collimated (i.e., the divergence is approximately zero). An object at a closer distance will have a larger angle of divergence. As a result, the eye will perceive the target to be at different locations based on the divergence of the rays of light entering the patient's eye.
  • the apparent distance of the target seen by the patient may be controlled. This may be accomplished for example by adjusting the optics. Such adjustments to the viewing conditions to which a patient is exposed may help the examiner characterize the patients vision and provide suitable correction.
  • the examiner may indicate this decision by pressing a “finish” button (not shown), and a printout of the examination result can be output using a printer or similar device (not shown) that is connected to the processor 40 .
  • the processor 40 may also automatically transmit the prescription via modem, internet or other appropriate communication medium to a remote location for lens manufacturing.
  • a prescription to correct low order aberrations including sphere, cylinder and axis, can be used for prescribing conventional ophthalmic lenses, or a “supervision” prescription to correct higher or even all orders of aberrations can be used to provide improved vision lenses, such as are described in co-pending U.S. patent application Ser. No. 10/044,304, filed Oct. 25, 2001 and entitled “EYEGLASS MANUFACTURING METHOD USING VARIABLE INDEX LAYER”, which is incorporated herein by reference.
  • the apparatus and methods described herein advantageously enable quantification of the subjective response of the patient by performing objective measurements, i.e., without relying on verbal communication with the patient regarding the quality of their vision.
  • objective measurements can be performed that determine the subjective response of the patient to different optical correction.
  • a prescription for correction of the refractive errors can be obtained that is superior to that determined by conventional objective measurement approaches.

Abstract

An apparatus for determining the refraction of a patient's eye includes a wavefront measurement device that determines aberrations in a return beam from the patient's eye viewing a target through a corrective test lens in the apparatus. The wavefront measurement device preferably outputs an display representative of the quality of vision afforded the patient through the test lens. The display may be, e.g., a representation of a Snellen chart convolved with the optical characteristics of the patient's vision, an overall quality of vision scale, or the optical contrast function, all of which are based on the wavefront measurements of the patient's eye. The examiner may use the display information to conduct a refraction examination or other vision tests without the subjective response from the patient.

Description

    BACKGROUND OF THE INVENTION
  • 1. Field of the Invention
  • The present invention relates generally to methods and apparatus for determining a person's visual characteristics, and more particularly to apparatus and methods for determining the refraction of the eye.
  • 2. Description of the Related Art
  • Phoropters are apparatus used by optometrists to determine a patient's visual characteristics, so that proper eye diagnoses can be made and eyewear can be prescribed. In conventional phoropters, a patient looks through the phoropter, in which various test lenses are disposed, at a target eye chart, referred to as a “Snellen chart,” while an optometrist moves the test corrective lenses into the patient's field of view. In some applications, the target may be positioned at a predetermined distance from the patient. The patient is then asked to verbally compare the quality of the perceived image as afforded by one lens versus the prior lens presented. The optometrist takes note of either an improvement or a deterioration in the patient's vision through such lenses. Systematically, the test progresses towards the “best” test lens entirely based on the patient's responses. The lens parameters are then used as the basis for a prescription for eyewear.
  • Unfortunately, as recognized herein, the patient can become fatigued during the process and/or misjudge the vision afforded by the various lenses. This can lead to the selection of a less than optimum prescription. Moreover, some patients, such as a very ill or a very young patient, might not be capable of articulating the quality of vision the various lenses afford the patient.
  • Objective methods of determining the patient's refraction errors have been proposed, but these other methods introduce further complications that are not present when using phoropters. In a retinoscopy method, for example, a streak of light is projected to a patient's retina, and the characteristics of the reflected light at the patient's corneal plane is analyzed to determine whether the patient is myopic, or hyperopic, and with or without astigmatism. However, the method does not provide sufficient accuracy for prescribing spectacle lenses. Consequently, its measurement results are typically used only as a starting point of a standard phoropter measurement.
  • Another objective measurement instrument for determining refractive errors is an autorefractor, which, owing to its speed of use, is more popular than retinoscopy. To use the autorefractor, a patient is asked to look inside an enclosed box that is part of the autorefractor. A target image is optically projected into patient's eye, and a series of lenses is automatically moved into position of the patient's line of sight to the target, to neutralize the patient's refractive errors (autorefraction). Unfortunately, the measurement outcome often differs from the patient's ideal prescription. Accordingly, like retinoscopy, autorefractor outcomes typically are used only as starting points for standard phoropter measurements.
  • Moreover, both retinoscopy and autorefraction fail to account for the accommodation effect of the patient, that is, for the propensity of a patient to alter his or her focus or sight to make the best of the vision test. An autorefractor measurement essentially is a snapshot of the patient's vision at a particular instant at which the autorefractor has identified a so-called neutralization point, and at this point if it happens that the patient focuses his vision for seeing an image at a distance other than what is intended, or if the patient is momentarily looking elsewhere other than the target, the output of the autorefractor is erroneous. Such deceptive focussing on the part of the patient can arise because the patient is conscious of the working distance inside the box, and when an image of an object presented to the patient which is modeled to be located at, e.g., twenty feet, the patient automatically focuses for an image at a much closer distance, knowing the actual size of the box. Examination results that include patient accommodation effects are inaccurate for prescribing spectacle lenses.
  • Another limitation of the autorefractor is that the examiner has no control over which lens is to be used in the test. The result is that repeated measurements are likely to provide different results for the same eye from the same patient, which results in laborious and time consuming tests and retests when using the device to finalize a prescription.
  • Thus, what is needed are improved methods and apparatus for measuring the optical properties of a person's eye.
  • SUMMARY OF THE INVENTION
  • One aspect of the invention comprises an apparatus for determining the refraction of a patient's eye focused on a physical target. The apparatus comprises a light source and optics that direct light from the light source to the patient's eye. The light reflects from a surface of the eye. This reflected light comprises a plurality of wavefronts. The apparatus further comprises a wavefront measurement device positioned along a first optical path to the eye to measure the shape of the wavefronts reflected from the patient's eye along this first optical path. At least one test lens is disposed along a second optical path between the patient's eye and the physical target. The optics and the at least one test lens are arranged such that when the patient looks at the physical target through the test lens, the light from the light source is directed through the eye so as to determine the refraction from the wavefronts returning from the eye.
  • Another aspect of the invention comprises a method of quantifying the quality of a person's vision. In this method, a test lens is provided through which the person views a physical target spaced from the test lens. Light is directed into an eye of the person when the person looks through the test lens at the physical target. Some of the light reflects from tissue in the eye such that the light propagates through an ocular lens and cornea of the eye and exits the eye. A wavefront of the reflected light emanating from the person's eye is measured. One or more values of a figure of merit are determined using the wavefront measurement. The figure of merit is indicative of quality of a person's vision. A graphic based on the one or more values of the figure of merit is produced. This graphic is indicative of the quality of a person's vision.
  • Yet another aspect of the invention comprises a method of characterizing a person's vision. In this method, corrective optics are provided for testing the vision. The corrective optics are variable to provide different amounts of optical correction for reducing optical aberration. A light beam is directed into an eye of the person. Light from this light beam reflects from tissue in the eye such that the light propagates through an ocular lens and cornea of the eye and exits the eye. The reflected light comprises a plurality of wavefronts. The wavefronts emanating from the person's eye are repetitively measured with the corrective optics adjusted to a substantially fixed amount of optical correction. A set of data points indicative of the quality of vision of the person for a given amount of optical correction are thereby produced. The average and variation in the plurality of data points are determined to provide an objective assessment of the correction.
  • In various embodiments, the corrective optics may be altered to provide different amounts of optical correction. The reflected light from the person's eye is repeatedly measured for each of the different amounts of optical correction, thereby yielding a set of data points for the different amounts of optical correction. The average and variation in the plurality of data points is determined for the different amounts of optical correction.
  • Another aspect of the invention comprises an apparatus for automatically determining correction for a patient's vision. This apparatus includes test optics for testing the vision, the test optics are variable to provide different amounts of optical correction. The apparatus further includes a light source and associated optics for directing light into an eye of the patient. The light from the light source reflects from tissue in the eye. This reflected light comprises a plurality of wavefronts that propagate through an ocular lens and cornea in the eye. In addition, a wavefront sensor that comprises one or more optical detectors for measuring the wavefronts emanating from the patient's eye is included in the apparatus. The wavefront sensors has an electrical output representative of the wavefront. An electrical processor is configured to receive the electrical output from the wavefront sensor and determine the quality of the patient's vision therefrom. Furthermore, a mechanical actuator is electrically connected to the processor. The mechanical actuator adjusts the test optics so as to vary the amounts of optical correction.
  • Still another aspect of the invention comprises a method of determining correction for a person's vision. In this method light is directed into an eye of the person. The light reflects from tissue in the eye. This reflected light comprises a plurality of wavefronts that propagates through an ocular lens and cornea in the eye. The wavefronts are measured with a wavefront sensor. At least one of the wavefronts is represented by a series of orthogonal components, εKnQn, where Qn corresponds to the orthogonal components and Kn corresponds to coefficients having values selected to substantially match the sum with the wavefront. The orthogonal components are weighted with psychometric weight factors Pn based on their relative influence on human vision. Optical correction is designed based on the wavefront representation and the psychometric weight factors.
  • Another aspect of the invention comprises a method of quantifying accommodation in an eye having a cornea, an ocular lens, and a retina. In this method, a light beam is directed into the eye. Light from the light beam is reflected from tissue in the eye such that the light propagates through the ocular lens and cornea of the eye and exits the eye. Wavefronts associated with the reflected light emanating from the eye are repetitively measured for a set of conditions that induce an amount of accommodation. A set of data points indicative of the quality of vision for the plurality of wavefronts measured under this set of conditions are thereby produced. The average and variation in the plurality of data points are determined to provide a measurement of the amount of accommodation.
  • In various embodiments, the reflected light from the eye is repetitively measured for another set of conditions that induce a different amount of accommodation thereby yielding an additional set of data points for this different amount of accommodation. The variation in the plurality of data points is determined to provide a measurement of this different amount of accommodation.
  • Yet another aspect of the invention comprises a computer readable medium having a program of instructions stored thereon for causing an electrical processor to execute method steps for identifying optical correction for a person's eye based on wavefront measurements of light reflected from said person's eye. These method steps comprise:
      • (a) calculating a value of a figure of merit indicative of the person's quality of vision, said value being derived at least in part from a measurement of a wavefront from said person's eye;
      • (b) retrieving another wavefront measurement;
      • (c) repeating steps (a) and (b) N times;
      • (c) calculating the average and variation of the figure of merit values and storing the average and variation as a data set for a given optical correction;
      • (d) repeating steps (a) through (d) for different optical correction; and
      • (e) selecting the optical correction that yields (i) the maximum average value of the figure of merit, (ii) the minimum variation of the figure of merit, or (iii) a value between those of (i) and (ii).
  • Yet another aspect of the invention comprises a phoropter that includes plural test lenses that can be disposed into a line of sight defined between a patient and a target, such that a patient looking at the target perceives light from the lens. A wavefront measurement apparatus is positioned to detect aberrations in light returning from the patient. These aberrations are caused by the eye of the patient.
  • The phoropter may further comprise a processor that outputs a diagnostic signal that corresponds to an objective assessment of the patient's quality of vision. The processor may be in communication with a display device for generating at least one visual display representative of an effectiveness of a test lens in correcting the patient's vision. The processor may employ the objective assessment of the patient's quality of vision to select a next test lens to determine a successive objective measurement of the quality of vision corresponding to the next test lens. In some embodiments, the processor may determine the standard deviation of the objective measurement of the patient's quality of vision and one or more successive objective measurements of the quality of vision for different test lenses and identify a substantially optimal vision correction lens for the patient. The objective assessment of the patient's quality of vision may also be useful for generating an image representation of the target.
  • In one preferred embodiment, a wavefront measurement apparatus includes a light source, such as a laser or light emitting diode (LED), for generating the light and a light detector that outputs a signal representative of the aberrations. Also, the apparatus includes a processor that receives the signal from the light detector and outputs a diagnostic signal representative thereof. The diagnostic signal is° useful for generating an image representative of the test object, and/or for generating at least one visual display representative of an effectiveness of the lens in correcting a patient's vision. The visual display can include a bar chart, a pie chart, and/or a line chart, and it can be color coded. The display may include, for example, (1) an image generated by a convolution of the image of the test object based on the wavefront returning from the patient's eye and through the lens, (2) a numerical and/or graphic display representative of the effectiveness of the lens, or (3) a numerical and/or graphic display of the contrast function of the patient's vision.
  • In still another aspect of the invention, a method for indicating the quality of a patient's vision includes providing a device through which a patient can look at a target. The method also includes directing a laser beam into the eye of the patient when the patient looks at the target, and then detecting aberrations in a wavefront of the light beam as the light beam returns from the patient's eye. Based on the wavefront, the method indicates a quality of a patient's vision. In various preferred embodiments the refraction for the patient is determined.
  • In some embodiments, this method may further include prescribing ophthalmic lenses for the patient. Ophthalmic lenses for correcting refractive errors of the patient may be prescribed and/or dispensed that are designed to reduce or correct (i) the low order aberrations including sphere, cylinder, and axis, or (ii) low order aberration in (i) and higher order aberrations including the third order and possibly higher Zernike terms.
  • In still another aspect, a method for indicating the quality of a patient's vision includes providing a device into which a patient can look, and that generates a substantially instantaneous visual indication of a quality of a patient's vision. The method may further include indicating the quality of a patient's vision by using at least one visual display representative of the effectiveness of a first lens in correcting the patient's vision. The display representing the effectiveness of the first lens may be evaluated and a second test lens may be selected. The second test lens may be positioned in the patient's line of sight and at least a second visual display representative of an effectiveness of the second test lens in correcting the patient's vision may be generated. Selecting the second test lens may include determining at least one of (a) the onset of the patient's accommodation, and (b) the range of the patient's accommodation. Fogging may be employed to select a more suitable lens for the patient.
  • In yet another aspect, a device for aiding a practitioner in knowing the integrated effect of a patient's eye and a test lens placed in front of the eye includes means for sensing an optical wavefront returning from the eye through the lens. Means are coupled to the wavefront sensing means for generating an indication of the integrated effect of the eye and the test lens.
  • In another aspect, a device for generating an indication of the quality of vision of a patient viewing a target includes a light beam generator directing light into the eye of the patient, and a wavefront sensing device detecting an optical wavefront returned from the eye of the patient while the patient is looking at the target. A computing device receives input from the wavefront sensing device that is representative of the wavefront. The computing device outputs a substantially continuous update of at least one of: a point spread function (PSF) and a modulation transfer function (MTF), while the patient is looking at the target. A display device displays at least one of: a simulated image of the target at the patient's retina, a quality of vision indicator indicating the quality of vision, and a graph indicating a contrast function of the patient, based at least in part on at least one of the point spread function and the modulation transfer function.
  • In yet another aspect, a vision quantifying device includes a beamsplitter through which a patient can look at a target. A source of light emits light into an eye of the patient, which reflects from the eye as a return beam. A processor receives a signal representative of a wavefront of the return beam and generates at least one signal in response thereto, and a display receives the signal and presents a visual indication of the patient's sight.
  • Another aspect of the invention is to provide automatic refraction correction. The patient looks at a target. A test lens is positioned between the target and the patient's eye, and in the line of sight of the patient. A light beam is directed through the test lens and into the patient's eye. Using a portion of that light reflected from a surface within the eye, a wavefront profile is reconstructed. From the reconstructed wavefront profile, a quality vision factor (“QVF”) may be calculated. In order to improve the accuracy of the measurements of the patient's eye, a number of measurements of the returning wavefront profile are taken, and the corresponding QVF values for each of the measurements for that particular test lens, is analyzed. The analysis of this data provides for a determination that the correction with that particular lens is optimal. If the correction is not optimal, a next test lens is selected, and the process is then repeated for the next test lens after it is positioned by mechanical means in the patient's line of sight. On the other hand, if the correction with that particular lens is optimal, then the process ends resulting in the proper refractive correction having been identified.
  • The details of the present invention, both as to its structure and operation, can be understood in reference to the accompanying drawings, in which like reference numerals refer to like parts.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a perspective view of one embodiment of an apparatus for characterizing a patient's vision, in one intended environment;
  • FIG. 2 is a perspective view of the apparatus, showing the patient;
  • FIG. 3 is a block diagram of the components of one preferred apparatus;
  • FIG. 4 is a flow chart of the some preferred logic;
  • FIGS. 5-9 are exemplary non-limiting diagrams of quality of vision displays; and
  • FIG. 10 is a flow chart showing an automatic refraction method described herein.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
  • Although this invention will be described in terms of certain preferred embodiments, other embodiments that are apparent to those of ordinary skill in the art, including embodiments that do not provide all of the benefits and features set forth herein, are also within the scope of this invention. Accordingly, the scope of the invention is defined only by reference to the appended claims.
  • Referring initially to FIGS. 1 and 2, an exemplary apparatus is shown, generally designated 10, and includes a housing 12 that can be mounted on a movable stand 14 for positioning the housing 12 in front of a patient 15 who might sit in an examination chair 16. As can be appreciated in cross-reference to FIGS. 1 and 2, the patient 15 can position his or her head against the housing 12. Alternatively, the housing 12 can be supported on the head of the patient 15 and/or be suspended from a flexible overhanging arm which may be attached to a stand, to provide weight balance and to facilitate mounting and dismounting of the head mounted-apparatus. In other embodiments, the apparatus can be co-mounted with a conventional phoropter (not shown), in which case the test lenses, described more fully below, can be established by the lenses of the conventional phoropter. Other configurations may also be practicable.
  • Now referring to FIG. 3, the patient 15 can look through the housing 12 to a target 18, such as but not limited to a Snellen chart. The target 18 can be positioned at any appropriate distance from the patient 15, e.g., twenty feet or closer. Preferably, the target 18 is a distance zo of about 8 to 20 feet from the patient's eye 15. Since the target 18 can be positioned at a distance that actually is the distance intended, the above-noted patient accommodation effects related to autorefractors, are reduced or eliminated. In some cases, a mirror may be inserted in the optical path between the system 10 and the target 18 to introduce a turn in the optical path. These reflectors may be employed, for example, to accommodate suitable placement of the target 18 such as on the ceiling of an office where the vision tests are being administered.
  • FIG. 3 shows one exemplary implementation of the housing 12. While FIG. 3 shows that various components are located inside the housing 12 and various other components such as the output display are located outside the housing 12, it is to be understood that the principles advanced herein apply to systems having multiple housings, or a single housing. Additionally, other component and configurations may be included in the design.
  • In the embodiment shown, the patient looks at the target 18 through a transparent window within the housing 12, such as can be established by a primary beamsplitter 20 or other optical element. Interposed in the line of sight of the patient 15 are one or more movable test lens 22. By “movable” is meant physically movable by hand or computer or electronically-controlled mechanism as indicated as “M” in FIG. 3, and more fully disclosed below, such that the lens is selectively interposed in or out of the line of sight of the patient 15. The test lens may also be movable in the sense that a variable focal length lens can be used, with its optical characteristics being variable in accordance with principles known in the art, for example those utilized in various designs of autorefractors. In certain embodiments, the test lens 22 can be, but should not be limited to, a single concave convex lens, or a combination of optical components such as lenses, and may include a cylindrical lens and a prism.
  • The test lens 22 may be disposed in an optical path between the primary beamspiitter 20 and the patient's eye 15 as depicted in FIG. 3. The distance yo between the test lens 22 and the eye is relatively small, compared, for example, to the distance to the target 18. The separation between the eye 15 and the lens 22 may, e.g., be between about 0.8 and 1.6 centimeters in some embodiments. In the case, where this separation is small, the distance from the test lens 22 to the physical target, zo−y0, is approximately equal to the distance zo from the eye to the target 18.
  • As also shown, a light source such as but not limited to a laser 24 generates a light beam 26 that can be directed, in one preferred embodiment, toward a laser beamsplitter 28. The laser beamsplitter 28 reflects the light beam 26 toward the primary beamsplitter 20, which in turn reflects the beam through the test lens 22 and onto the eye of the patient.
  • Note that in certain embodiments, the test lens 22 may be inserted in the optical path between the beamsplitter 20 and the target such that the laser beam 26 does not pass therethrough. However, in either case where the test lens 22 is employed, preferably the vision is at least partially corrected. Measurements may be more accurate when vision is good and the eye is not stressed and is operating more normally.
  • With reference again to FIG. 3, after reaching the eye, the beam 26 is reflected therefrom, back through the lens 22, and is reflected off the primary beamsplitter 20. The beam passes through the laser beamsplitter 28, and a portion of the beam is reflected off a pupil detection beamsplitter 30 toward a pupil light detector 32 through one or more focussing lenses 33, for purposes to be shortly disclosed. A portion of the return beam passes through the pupil detection beamsplitter 30 and propagates through an optical relay unit 34, which focuses the beam onto a wavefront analyzer optics 36. The wavefront analyzer optics 36 generates a signal representative of the wavefront of the return beam, and a wavefront detector 38 transforms the signal into an electrical signal for analysis by a processor 40. In one preferred embodiment, the processor 40 can be associated with control electronics known in the art for undertaking control of one or more components (e.g., the light source 24) of the system 10 as more fully set forth below. Also, the processor 40 can generate the below-described visual indications of the patient's vision as corrected by the test lens 22 and can cause the indications to be displayed on a display device 42, such as a video monitor, that can be mounted on the housing 12 or apart therefrom. The display device 42 can be a liquid crystal display that can be mounted on the housing 12 of the system 10, or a stand-alone display unit conveniently located for the examiner's viewing. Suitable displays may include, but not be limited to, numerical and/or graphical representations indicative of the patient's quality of vision, as described more fully below.
  • If desired, an illumination light 44, e.g., a ring-shaped fiber optic, can be mounted on the housing 12 and can be connected to the processor 40 to control the pupil size of the patient 15. The illumination light 44 can be a source of diffused light. The light intensity of the illumination light 44 may be controlled by the processor 40 in response to feedback from the pupil light detector 32, which can comprise, e.g., a CCD camera, or reticon detector array to monitor the size of the pupil, so that a predetermined pupil size can be maintained for the patient during the measurement. The locations of the pupil detection unit, including the components, beamsplitter 30, lens 33, and pupil light detector 32, can be in other appropriate locations along the optical path of the return light from the eye, including locations inside the optical relay unit 34.
  • As a further improvement to the accuracy of the refraction measurement, the system also monitors the first Purkinge image, an image formed by reflection at the anterior surface of the cornea of the light beam 26. The position of this image relative to the pupil boundary is an indication of gazing direction of the patient under examination. Unless the patient has strabismus in that eye, the relative position of the First Perkinge image is a well defined bright spot, and it is typically inside the pupil boundary. Therefore, in a preferred but non-limiting embodiment, the pupil detector 32 can also function as a patient gazing monitor. In this case, the relative position of the First Perkinge image to the pupil is determined by processing of the image data from the CCD camera, for example, using data filtering, contrast enhancement, and pupil boundary determination methods known in the art.
  • In various embodiments, software processing can be done in real time in a matter of a fraction of a second. The objective of this analysis is to determine whether the patient is looking at the target, or momentarily drifting off. The information is electromagnetically transmitted to the central control unit 40. If the patient is not looking at the target, the data set from the wavefront detector unit 38 is rejected, and preferably is not displayed or accumulated for data analysis.
  • As indicated above, the following comments are germane to implementation details of preferred, non-limiting embodiments. The light source 24 can be a diode laser that emits light at near infrared wavelengths. Moreover, the light detectors 32, 38 can be implemented by CCD arrays or linear reticon arrays or other detection devices. Further, the primary beamsplitter 20 can be coated to transmit visible light and to reflect infrared light. On the other hand, the laser beamsplitter 28 can be a polarization dependent reflector, in which case the laser light is polarized, and a quarter wave plate (not shown) is disposed in the beam path to the patient 15 such that the return beam is rotated ninety degrees (90°) upon double passing the quarter wave plate for facilitating passage thereof through the laser beamsplitter 28 toward the wavefront analyzer optics 36. Alternatively, the laser beamsplitter 28 can be plate coated for high transmission and low reflectivity at forty five degrees (45°) incident angle, such that only a small portion of the laser light is reflected into the eye, but a high percentage of the return light propagates through the laser beamsplitter 28.
  • Continuing with the implementation details of a preferred, non-limiting embodiment, the optical relay unit 34 can include two convex lenses F1 and F2 that together establish a telescope. The lenses F1, F2 are separated from each other by a distance equal to the sum of their focal lengths, with the focal plane of the first lens F1 being located at the front surface of the test lens 22, i.e., the surface facing the primary beamsplitter 20. In the case where the lens 22 is not between the patient's eye 15 and the primary beamsplitter 20 (e.g., wherein the test lens is between the primary beamsplitter and the target 18), the focal plane of the first lens F1 is preferably located at the front of the eye, i.e. the front of the cornea. The focal plane of the second lens F2 is located at the image plane of the wavefront analyzer optics 36. The purpose of the telescope structure of the relay unit 34 is to relay the wavefront at the exit surface of the test lens 22 to the image plane of the wavefront analyzer optics 36. Alternative relay optics can be used to achieve the same or different purpose.
  • With respect to the non-limiting details of the wavefront analyzer optics 36, the optics 36 can include an array of lenslets arranged as in a Shack-Hartmann wavefront sensor, an example of which can be found in page 37, “Customized Corneal Ablation The Quest for Super Vision” edited by MacRae, et. al. published by Slack Incorporated, 2001, incorporated herein by reference. Various Shack-Hartmann wavefront sensors and processors are available, for example, from commercial vendors such as Wavefront Sciences, in Albuquerque, N. Mex., Zeiss/Humphrey Instruments, in Dublin, Calif., or Bausch and Lomb, in Irvine, Calif. More preferably, the optics 36 can include ruled reticles such as those disclosed in co-pending application U.S. patent application Ser. No. 10/014,037, entitled “SYSTEM AND METHOD FOR WAVEFRONT MEASUREMENT”, filed Dec. 10, 2001, and U.S. patent application Ser. No. 10/314,906, entitled “SYSTEMS AND METHODS FOR WAVEFRONT MEASUREMENT”, filed Dec. 9, 2002, both of which are incorporated herein by reference, which use a self-imaging diffraction principle to detect the wavefront in the return beam.
  • Regardless of the type of wavefront analyzer optics 36 used, the processor 40 analyzes the profile of the wavefront of the light returned from the patient's eye, and quantifies the wavefront aberrations in two regimes: low order aberrations, including spherical refractive error, cylinder, and axis, and higher order aberrations, including coma, spherical aberrations and other higher order terms that can be described by Zernike polynomials. Quantitative data representing the patient's quality of vision are then graphically presented on the display device 42.
  • Now referring to FIG. 4, an exemplary mode of operation of an apparatus such as depicted in FIG. 3 can be seen. The patient 15 views the target 18 through the system 10, and in particular through the transparent window that is established by the primary beamsplitter 20. At block 44, the examiner initiates the vision test by inserting a selected test lens 22 in the line of sight of the patient, or by configuring a variable focal length lens 22 to have a predetermined focal length. Inserting means either manual positioning or positioning using a motor or other translation or rotation mechanism. In certain embodiments, the processor 40 can select a particular lens 22 and cause it to be automatically moved in the line of sight, in accordance with discussion below.
  • Various steps represented by blocks in FIG. 4 involve calculations, and other types of activities that can be automated and at least partially implemented using for example computer logic. In particular, in accordance with processes and methods described and shown herein. These methods and processes include, but are not limited to, those depicted in at least some of the blocks in the flow chart of FIG. 4 as well as the flow chart in FIG. 10, which is described more fully below. These and other representations of the methods and processes described herein illustrate the structure of the logic of various embodiments of the present invention which may be embodied in computer program software. Moreover, those skilled in the art will appreciate that the flow charts and description included herein illustrate the structures of logic elements, such as computer program code elements or electronic logic circuits. Manifestly, various embodiments include a machine component that renders the logic elements in a form that instructs a digital processing apparatus (that is, a computer, controller, processor, etc.) to perform a sequence of function steps corresponding to those shown.
  • In other words, the logic may be embodied by a computer program that is executed by the processor 40 as a series of computer- or control element-executable instructions. These instructions may reside, for example, in RAM or on a hard drive or optical drive, or the instructions may be stored on magnetic tape, electronic read-only memory, or other appropriate data storage device.
  • Proceeding to block 46 in FIG. 4, the processor 40 determines the point spread function (PSF) that is derived from using, for instance, the terms of Zernike polynomials, which is in turn derived from the wavefront passing through the wavefront analyzer optics 36 and transformed into an electrical signal by the wavefront detector 38 when the wavefront data is acquired. The processor 40 may Fourier transform the signal from the wavefront detector 38 using the following equation:
    PSF(x,y)=|FT(P(x,y))|2
    wherein FT designates a Fourier Transform calculation and P(x, y) is the spatial distribution of the wavefront profile of light with the same phase (i.e., phase front) returned at the corneal plane.
  • Proceeding to block 48, if desired, an Optical Transfer Function (OTF) can be calculated from an inverse operation of Fourier Transform as follows:
    OTF(f x ,f y)=FT −1(PSF(x,y)),
    wherein fx, fy are spatial frequencies in x and y directions, respectively, that are orthogonal to each other.
  • Moreover, a Modulation Transfer Function (MTF) can be determined as the amplitude of the OTF:
    MTF(fx ,f y)=|OTF(f x ,f y)
  • The above functions are used to generate visual indications of the quality of vision that is afforded by the test lens 22 currently being viewed by the patient 15. For instance, once the PSF is determined at block 46, the logic can flow to block 50 to determine a convolution function G as follows:
    G(X img , Y img)=∫∫PSF(x−x img ,y−img)f(x img ,y img)dxdy,
    wherein f(x img , y img) is the test target 18 (FIG. 3), i.e., an ideal image function, ximg−ximg is the difference in the x-dimension between each point in the PSF and the corresponding ideal point in the ideal image, and y−yimg is the difference in the y-dimension between each point in the PSF and the corresponding ideal point in the ideal image.
  • The convolutional function G can be used at output state 52 to generate an appropriately blurred image, point by point, of an ideal image as affected by the imperfection of the patient's eye in combination with the lens 22. For example, when the target 18 is a Snellen chart, the ideal image function can be the letter “E” or a series of other letters, e.g., of various physical sizes as conventionally used in the various lines in the Snellen chart. FIG. 5 shows one such blurred image at 54, which can be presented on the display 42. Alternatively, the target can be a picture, and the convolved image G(ximg, yimg) Of the picture is blurred point by point, according to the PSF, which represents an image of the target formed at the patient's retina.
  • Accordingly, the letters in the simulated blurred image have the same blurring as perceived by the patient 15. In this way, the examiner can visualize the clarity and sharpness of the image as a result of the lens 22 as it is perceived by the patient 15.
  • Alternatively or in addition to the image shown in FIG. 5, the processor 40 can generate the displays shown in FIGS. 6-8 as follows. At block 56 the wavefront profile, as indicated by the above-mentioned linear combination of Zernike polynomials, is filtered to eliminate terms with coefficient below a threshold amplitude. Moving to block 58, a psychometric weighting factor “P” is inserted for each of the remaining Zernike terms as shown in the following. This weighting factor “P” represents the effect of the brain to discriminate objects despite certain types of ocular aberrations. For example, most people can discern a letter in a Snellen chart with a certain amount of defocus while the same amplitude of aberration in coma would not allow the same patient to discern that letter. To compensate for this, a Quality of Vision Factor (QVF) is determined as follows:
    QVF=exp−εnPnZn 2 )
    wherein Pn is the psychometric weight factor for the corresponding nth term of the Zernike polynomials, and Zn is the coefficient of the nth term of the Zernike polynomials in the PSF.
  • The psychometric weighting factors “Pn” can be determined by presenting a particular aberration to a normative group of people representing an average population distribution, for example, between about two hundred to several thousand people, depending on the accuracy level desired and the range of the scatter value of each type of aberration measurement. The patients are presented one at a time with particular types of aberrations selected from the Zernike polynomials, and then the patients are scored for the extent of success in discerning the target, for example, by the number of letters correctly read on the Snellen chart, or other standardized vision test chart. Other methods based on contrast level, standardized letter size, sine or square wave patterns can also be used. For example, success of patients in discerning graphics consisting of lines having various cycles per degree may be employed to test contrast sensitivity.
  • The optical element for introducing such aberration can be an aberration plate on which a selected type of aberration has been imprinted. For example, the aberration type can be a coma, or a trefoil, having a refractive index profile to produce the proper phase changes as specified by the corresponding Zernike polynomial.
  • The relative effect of each type of aberration is tabulated for the group and averaged to obtain statistically meaningful weight factors. For most practical purposes, Zernike coefficients for terms higher than the sixth order (term number twenty nine or higher) minimally contribute to the overall aberration profile of normal eyes. The method of producing various types of aberrations with desired amplitudes according to each of the Zernike terms is set forth in co-pending U.S. patent application Ser. No. 09/875,447 filed Jun. 4, 2001 and entitled “WAVEFRONT ABERRATOR AND METHOD OF MANUFACTURING”, which is incorporated herein by reference. In the event that no data for the psychometric weight factors are available, all weighting factors Pn can be set to unity.
  • Once the QVF has been determined, one or more of the displays shown in FIGS. 6-8 can be generated and displayed as indicated in block 60. For example, as shown in FIG. 6, a bar chart display can be generated to present an overall indication of the patient's quality of vision as afforded by the lens 22 under test. As shown, the indicator can be in the form of a graduated bar 62, the height of which is proportional to the QVF determined at block 60, with zero indicating poor vision and perfect vision being indicated by a bar extending from the bottom to the top 64 of the scale. If desired, the display scale can be a log scale, in which case the “best” is indicated by the bar 62 being at zero, and rising logarithmetrically with worse vision using a root-mean-square function of the QVF. Enhancements to the bar 62 such as color-coding can be used. For instance, the bar 62 can be colored red for poor vision and green for good vision, with other colors being used to indicate intermediate qualities of vision. In lieu of the bar chart of FIG. 6, the QVF can be used to generate a pie chart as shown in FIG. 7, with the size of a pie slice 66 relative to the entire circle being linearly or logarithmetrically proportional to the QVF.
  • The system 10 can substantially continuously measure the wavefront profile of the light beam returned from the patient's eye. Accordingly, in one preferred, non-limiting embodiment, a sequence of QVF measurements (e.g., twenty) for a single test lens 22 can be made in a second or two and grouped together.
  • As described earlier, the measurement accuracy can be improved by monitoring the gazing direction of the patient, and the computing device in block 40 can reject the data points acquired when the patient was not looking at the designated target. Furthermore, the computing device can also accumulate data and perform calculations for average values and standard deviation for selected subsets of measurement.
  • FIG. 8 shows a resulting display. As can be appreciated from the exemplary embodiment shown, five lenses 22 have been tested and several QVF values obtained over a short period for each. Each group of QVF values is plotted as a respective vertical line 68 on a plot of QVF versus lens, with the length of each error bar line 68 representing the standard deviation of the measurements for that particular lens and the center of each line representing the mean QVF value. The prescription can be based not only on a high mean QVF value, as indicated at points 70 and 72, but also on a small standard deviation, as indicated by bar 74. That is, the lens corresponding to the bar 74 might be selected because its QVF values had a small standard deviation from each other and it had a high mean QVF value, even if not as high as the point 70. This recognizes that some patients prefer a lens power which may not necessarily provide the sharpest image but which does result in more comfort, since a patient does relatively little searching for the “better focus” using lenses that exhibit smaller standard deviations in the QVF. An example case is a patient who has not had a vision check for an extended period of time and requires correction of more than 1.5 diopters in cylinder. The patient may feel uncomfortable with the full correction as afforded by the sharpest image; rather the patient may prefer a smaller amount of correction which represents improvement in his vision, yet that does not cause dizziness or head strains. Therefore, embodiments of the present invention may provide objective data based on the subjective response of the patient to a test lens set 22 presented to the patient.
  • Determining the variation in the figure of merit preferably involves performing multiple measurements with consecutive measurements separated by a sufficiently long time interval. This time interval is preferably long enough to permit the eye to adjust its focus. Thus, the variation in data points should reflect adjustments made by the eye such as are present when the eye is straining to focus or accommodate. The time period between consecutive measurements is therefore preferably between about 0.1 to 5 seconds, however, values outside this range are also possible.
  • Accordingly, various test conditions may be presented to the patient under examination to investigate the subjective responses to such conditions. For example, as described above with reference to FIG. 8, objective measurements are performed to determine the subjective response of the patient to different optical correction. By taking into account the subjective aspect of the patients vision experience, a prescription for correction of the refractive errors that is superior to that obtained with conventional objective measurement approaches is possible. Other conditions can be altered and the subjective response of the patient determined using the objective measurements described herein. Fogging and testing for the range of the accommodative ability are some other examples of how conditions that affect vision may be controlled and tested. In each of these cases, the apparatus and methods described herein advantageously can enables quantification of the subjective response of the patient by performing objective measurements, i.e., without any verbal communication with the patient.
  • As recognized herein, to determine a patient's ability to resolve patterns having varying levels of contrast, the patient can be presented with a series of standardized patterns of sine wave gratings of increasing spatial frequency frequencies, with the patient offering subjective responses. The resulting examination report can be a curve that depicts a cutoff contrast intensity at various spatial frequencies. Embodiments of the present invention can provide a quantitative evaluation of a patient's ability to handle contrast, which can be generated in addition to or in lieu of those displays discussed above. Such a display can be generated at output state 76 in FIG. 4 and is shown in FIG. 9, showing a curve 78 depicting actual patient optical contrast function (OCF) and a reference curve 80 depicting a diffraction-limited reference. To determine OCF, the following relation may be used:
    OCF=MTF×M iat.
    wherein MTF is the modulation transfer function determined at block 48 and Miat is a mathematical function accounting for the low frequency filtering of the neural system, the value of which linearly increases with spatial frequencies with a slope of unity in a log-log scale plot and reaches the maximum value of one at and above the spatial frequency of seven cycles per degree.
  • Accordingly, the OCF does not include the effect of the brain processing at frequencies higher than seven cycles per degree, but it does provide valuable information about the patient's ability to discern sine gratings of various spatial low frequencies based on a patient's optics.
  • The above process of measuring (and displaying) indications of the improvement in vision afforded by a particular test lens 22 to the patient 15 can be continued at block 82 until the “best” test lens is found. This can be done by the examiner manually swapping lenses 22 as, e.g., in a conventional phoropter. As mentioned above, in other embodiments, the positioning of test lenses 22 can be done automatically by the processor 40 controlling the moving mechanism “M”, which can include a motor (or actuator) and coupling structure connecting the motor/actuator to one or more lenses 22. With this configuration, the mechanism follows an instruction from the processor 40 to insert the particular lens in the line of sight of the patient, as requested by the processor.
  • When done by the processor 40, the sequence of test lenses 22 to be used in an examination may be programmed into the processor 40 in accordance with examination strategy and routines known in the art. The starting lens can be selected based on the patient's current spectacle prescription or based on the wavefront measurement without any test lens 22 in the patient's line of sight. Consequently, in reconstructing the return beam wavefront without a test lens 22 being in the beam path, the processor 40 essentially models the uncorrected aberrations of the patient's eye in Zernike terms.
  • Recall that the second order Zernike terms represent defocus, astigmatism and axis information. Based on the patient's pupil size and the uncorrected wavefront error amplitudes, the processor 40 can determine the equivalent diopter power in sphere and cylinder and its axis, and select the appropriate lens 22 being used to start the examination. In selecting test lenses 22, the processor 40 can use the above-disclosed QVF values or other figures of merit in lieu of subjective responses from the patient, and can then execute the examination strategy as if it is performed with the subjective response from the patient.
  • The automatic refraction process is depicted in FIG. 10, and generally designated 100. Process 100 begins with a first step 102 wherein the patient looks at a target. In step 104 a test lens is positioned between the target and the patient's eye, and in the line of sight of the patient. A light beam is directed through the test lens and into the patient's eye in step 106. As discussed earlier, the test lens may be positioned outside of the light beam, yet in the line of sight of the patient, positioned between the beam splitter 20 and the target 18 in FIG. 3. In this configuration, the patient's vision is affected by the test lens as he is looking at the target, but the wavefront emerging from the patient's eye is directed to the wavefront sensor without passing through the test lens, and thus this wavefront contains both the low order and higher order aberrations of the patient's eye.
  • In step 108, the light returning from the patient's eye is detected. From this detected light, the wavefront profile may be reconstructed, as shown in step 110. From the reconstructed wavefront profile, the quality vision factor (“QVF”) may be calculated in step 112. In order to improve the accuracy of the measurements of the patient's eye, “N” number of measurements are performed using the returning light. Accordingly, “N” wavefront measurements are taken, thereby yielding N wavefront profiles and corresponding QVF values. These successive measurements are taken by returning from step 112 to step 108, in which the returning light is again detected. Steps 108 through 112 are executed “N” times for the test lens. As described above, the “N” measurements are spaced apart in time by a sufficient amount to allow the patient to adjust their focus. For example, this time interval is preferably long enough to permit the muscles in the eye to readjust.
  • Once “N” measurements have been taken and the QVF for each measurement has been calculated, the QVF for that particular test lens is analyzed in step 114. The analysis of this data provides for a determination whether the correction with that particular lens is optimal. This decision is made in step 116, and if the correction is not optimal, a next test lens is selected in step 120, and the process returns to step 104 where the next test lens is positioned in the patient's line of sight. On the other hand, if the correction with that particular lens is optimal, then the process ends in step 122 resulting in the proper refractive correction having been identified. In other embodiments, the optimal lens may not be identified immediately after that particular lens is tested on the patient. Instead, the suitable lens may be selected after trying one or more additional test lens. Such is the case wherein a figure of merit analysis like that illustrated in FIG. 8 is employed.
  • In a typical refraction process, a series of lenses in ¼ diopters increments are used to determine the patient's optical correction. However, in various embodiments of the present invention, more or less than the typical number of lenses may be used, and the diopter increments can be in ⅛ instead of ¼, depending upon the magnitude of correction necessary. Also, as shown in FIG. 10, a number (“N”) of measurements of the returning light are performed in steps 108 through 112 to calculate the QVF for the particular test lens. In some embodiments, for example, 5-20 separate measurements (i.e., “N” equals 5-20) are performed to provide an accurate measurement of the QVF. However, more or less measurements may be performed depending upon the particular wavefront sensor device used, and the magnitude of correction necessary.
  • The prescription can be determined by a person viewing the display, e.g., of FIG. 8, or automatically by the processor 40 based on a high QVF value and low standard deviation, as follows: The examiner, or the processor 40 will examine the curve shown in FIG. 8, which connects the average values of the QVF's for various lens sets presented to the patient. Certain embodiments may include the step of performing a best fit to the average values, using a polynomial of up to 4 orders, for example. The processor 40 searches for the maximum value, of the “peak” of the curve. This can be accomplished by monitoring the peak value of the curve, or the slope of the curve, e.g., from decreasing lens power, from right to left, in FIG. 8. When the curve reaches its maximum value, the slope changes sign, and the maximum is at the zero slope value. Now, the processor 40 sends the peak value of the QVF and the corresponding lens power to the display or a printer.
  • Additionally, the processor 40 may also search for the minimum value among the standard deviation in the data set such as shown in FIG. 8. A figure (not shown) similar to FIG. 8 showing standard deviations versus lens power can be useful in determining the minimum value. Again curve fitting can be employed. The minimum value may be identified for example by detecting the sign change in the slope as described above for determining the maximum QVF value. Again, this minimum standard deviation value and the corresponding lens power are sent to the display device or a printer for record. For example, on the display or the printout the processor may indicate that lens power with the maximum QVF value provides for the sharpest image, while the lens power with the minimum standard deviation provides for the most comfortable prescription to the patient.
  • In certain embodiments both the average value of the figure of merit and its variation, e.g., the standard deviation, may be employed together to determine the suitable correction. The optical correction selected may for example be substantially equal to an amount between the optical correction yielding the least variation and the optical correction yielding the least aberration.
  • While FIG. 3 illustrates a system 10 wherein the return beam from the lens 22 is detected and analyzed and, hence, the integrated effect on the wavefront introduced by the eye and lens 22 is measured, it is to be understood that as mentioned above the return beam from the eye can also be analyzed without passing through the lens 22. The test lens 22 may for example be located between the primary beamsplitter 20 and the target 18. In such an embodiment, the effect of the lens 22, which has a known deviation from spherical, can be accounted for by adding or subtracting the lens 22 effect as appropriate from the eye-only wavefront. To facilitate this, in some embodiments a sensor (not shown) can be provided that senses which lens 22 is moved into the patient's line of sight. The sensor sends a signal representative of the lens 22 (and, hence, of the optical contribution of the lens) to the processor 40.
  • In any case, it may now be appreciated that if desired, the examiner can use conventional tactics in the steps of selecting test lenses 22 as if the whole process were done using a conventional phoropter that requires subjective responses from the patient. For example, the examiner can use “fogging” in accordance with principles known in the art to form an artificial image before the retina of the patient to cause the patient to relax the above-mentioned accommodative power. However, as a result of the display capability of the system 10, the examiner can identify the test lens 22 with which the patient achieves good vision without accommodation, regardless of patient verbal cooperation or ability to judge and articulate which lens 22 is preferable.
  • Advantageously, embodiments described herein may be suitable for quantifying accommodation. For example, the variation in the vision figure of merit may be determined for a variety of conditions that may induce differing amounts of accommodation. These conditions may include, for instance, distances from the eye to the target. Additionally, these conditions may include different amounts of optical power in the case wherein optics are inserted in the optical path between the eye and the target. By varying these conditions, the eye may accommodate. This accommodation may be characterized, for example, by determining the average value of the N measurements and the variation in the figure of merit values with varying condition and its corresponding accommodation response of the patient. In one approach the examiner may observe the displays and continue to decrease the focusing power (or increase minus power) of the test lenses being used, thereby moving the image behind the patient's retina. For example, if the patient is under the age of 40 years old, the patient's accommodative power may be in the range of 1 to 5 diopters, with younger patients tending to have greater accommodative power. For young hyperopic patients, determining the onset of accommodation is typically an important task to avoid an over minus corrective power in prescribing spectacle lenses. Using a preferred method, the examiner may find both the accommodative onset and the range of accommodation. The examiner may start with a higher corrective power lens than what is optimal for the patient that causes the image of the target to fall in front of the retina. The approximate optimal power may be determined from an autorefractor measurement, or measured directly from the patient's spectacle lenses. The starting power for the test lens is then preferably chosen to be 1 to 3 diopters higher than the approximate optimal power. The quality of vision and the figure of merit value is below the optimal value at this point. Then the examiner may decrease the corrective power of the test lens, thereby bringing the target into sharper focus, and an improved figure of merit of vision which is also shown by the increase of the average value of the figure of merit. This continues until a peak average value of the figure of merit is reached. This peak value is noted as the actual optimal refractive correction for the patient. So far, the examiner has performed a process that in many respects is similar to a traditional fogging, except that the entire procedure is done using a objective method and no verbal communication is needed. For older patients who have no accommodative power, any further decrease of the refractive power of the test lens would cause the figure of merit value to drop. However, for the young patients, accommodation would be applied to cancel the over minus effect of the test lens, so that the patient's focusing effort results in a sharp image of the target. The average value of the figure of merit does not drop appreciably at this point, but only slightly and leveling to form a plateau. Until the over minus power exceeds the accommodative range of the patient, the figure of merit value curve starts to drop. The width of the plateau is an indication of the patient's range of accommodative power. One aspect of this method is that while the patient may be able to see the target with reasonable sharpness using his accommodation, the extra efforts to drive the accommodation causes the focusing power of the eye to be unstable, which is manifested in the variation of the figure of merit value, or more specifically from the standard deviation calculation based on the number of repeated measurements. The error bars representing the standard deviation if plotted over the average value curve as a function of the diopter power of the test lenses, similar to the one shown in FIG. 8 would typically show larger standard deviations with more efforts to accomplish focusing when looking through the over minus power lenses (curve not shown). For a young hyperopic patient, who has not had his eye properly corrected, he may be conditioned to accommodate and often times the patient actually prefers to accommodate while looking at distant objects. In this case, the standard deviation error bar may be smaller than at the zero accommodation point where the curve first reaches its maximum value. If in fact this is the case, a prescription may, for example, be chosen to be a mid point between the zero accommodation point and the point with the minimum standard deviation. This example illustrates an aspect of this method in that the figure of merit data together with its standard deviations over N measurements, N may be in the range of, e.g., 3 to 10, are manifesting the subjective response of the patient as he reacts to various test lenses or other stimuli. Therefore, the aspect of using the average and the deviation of a figure of merit of vision has the ability of detecting subjective responses by studying the variation of the figure of merit over repeated measurements of the same test lens while the entire measurement is performed in an objective manner. The examiner can thereby determine the range of accommodation of the patient based on the objective measurements provided by the apparatus 10 and also provide a prescription to reduce accommodation or hyperopia errors.
  • As described above, in various embodiments, repetitive measurements used in determining optical correction, accommodation, or other vision properties are spaced apart over time intervals that are sufficiently long to allow the person under examination to adjust the focus of their eye. Consequently, the information gathered by the system represents the physical response of the person to the various conditions to which they are exposed. Thus, by allowing the person time to adjust to the various test conditions, and measuring the quality of vision responding to such conditions repeatedly, objective measurements can be obtained of the subjective responses of the patient without communicating with the person verbally, which is required when performing a manifest refraction using a conventional phoropter.
  • Specific examples of conditions that may be modified to characterize a person vision may include but are not limited to variations in test optics that are positioned in the line of sight as well as changes in the target distance. The target distance can be modified by moving the physical target. In addition, the apparent distance of the target can be changed by manipulating the beam of light from the target to the eye.
  • The apparent distance of the target can be controlled by altering the beam of light from the target to the eye. The patient's eye collects a portion of the light emanating from the target. The divergence angle of these collected rays will depend on the location of the target. For example, as is well known, light from a point object at the infinity is collimated (i.e., the divergence is approximately zero). An object at a closer distance will have a larger angle of divergence. As a result, the eye will perceive the target to be at different locations based on the divergence of the rays of light entering the patient's eye. Thus, by adjusting the divergence properties of the rays of light or the associated wavefronts, the apparent distance of the target seen by the patient may be controlled. This may be accomplished for example by adjusting the optics. Such adjustments to the viewing conditions to which a patient is exposed may help the examiner characterize the patients vision and provide suitable correction.
  • Once the appropriate lens 22 has been identified, the examiner may indicate this decision by pressing a “finish” button (not shown), and a printout of the examination result can be output using a printer or similar device (not shown) that is connected to the processor 40. The processor 40 may also automatically transmit the prescription via modem, internet or other appropriate communication medium to a remote location for lens manufacturing. A prescription to correct low order aberrations including sphere, cylinder and axis, can be used for prescribing conventional ophthalmic lenses, or a “supervision” prescription to correct higher or even all orders of aberrations can be used to provide improved vision lenses, such as are described in co-pending U.S. patent application Ser. No. 10/044,304, filed Oct. 25, 2001 and entitled “EYEGLASS MANUFACTURING METHOD USING VARIABLE INDEX LAYER”, which is incorporated herein by reference.
  • Accordingly, the apparatus and methods described herein advantageously enable quantification of the subjective response of the patient by performing objective measurements, i.e., without relying on verbal communication with the patient regarding the quality of their vision. Namely, objective measurements can be performed that determine the subjective response of the patient to different optical correction. By taking into account the subjective aspect of the patient's vision, a prescription for correction of the refractive errors can be obtained that is superior to that determined by conventional objective measurement approaches.
  • Those skilled in the art will appreciate that the methods and designs described above have additional applications and that the relevant applications are not limited to those specifically recited above. Also, the present invention may be embodied in other specific forms without departing from the essential characteristics as described herein. The embodiments described above are to be considered in all respects as illustrative only and not restrictive in any manner.

Claims (62)

1. An apparatus for determining the refraction of a patient's eye focused on a physical target, said apparatus comprising:
a light source;
optics directing light from said light source to the patient's eye, said light reflecting from a surface of said eye, said reflected light comprising a plurality of wavefronts;
a wavefront measurement device positioned along a first optical path to said eye to measure the shape of said wavefronts reflected from the patient's eye; and
at least one test lens disposable along a second optical path between the patient's eye and the physical target,
wherein said optics and said at least one test lens are arranged such that when said patient looks at said physical target through said test lens, said light from said light source is directed through said eye so as to determine said refraction from said wavefronts returning from said eye.
2. The apparatus of claim 1, further comprising a beamsplitter for merging said first optical path from said wavefront sensor to said eye and said second optical path from said eye to said physical target such that they overlap in a region between said beam splitter and said eye.
3. The apparatus of claim 1, wherein said test lens is disposed in said region between said patient's eye and said beamsplitter where said first and second optical paths overlap.
4. The apparatus of claim 1, wherein said test lens is disposed in said second optical path from said eye to said physical target outside said first optical path from said wavefront sensor to said eye.
5. The apparatus of claim 1, wherein said test lens is positioned an optical path length of approximately zo from said physical target, said eye being adjusted to focus on said physical target said distance, zo, away from said eye.
6. The apparatus of claim 5, wherein said test lens is positioned an optical path length of about zo−yo from said physical target, where yo corresponds to the optical path length from said test lens to said patient's eye.
7. The apparatus of claim 6, wherein said optical path length distance, zo−yo, between said lens and said physical target is about 8 feet or greater.
8. The apparatus of claim 6, wherein said distance, z−yo, between said lens and said physical target is about 20 feet.
9. The apparatus of claim 6, wherein said distance, yo, between said eye and said test lens is between about 0.8 and 1.6 centimeters.
10. The apparatus of claim 6, wherein said distance, yo, between said eye and said test lens is between about 0.5 and 4.0 centimeters.
11. The apparatus of claim 1, further comprising a housing containing said wavefront measurement device, said housing including a substantial ly transparent window disposed in said second optical path between said patient's eye and said physical target such said patient's eye can focus on said physical target.
12. The apparatus of claim 11, wherein said test lens is contained in said housing.
13. The apparatus of claim 1, wherein said light source is selected from the group consisting of (i) a laser and (ii) a light emitting diode.
14. The apparatus of claim 1, wherein said wavefront measurement device includes at least one light detector receiving the light returning from the patient's eye and sending a signal to at least one processor, said at least one processor generating at least one diagnostic output based on said wavefront measurements.
15. A method of quantifying the quality of a person's vision, comprising:
providing a test lens through which said person views a physical target spaced from the test lens;
directing light into an eye of the person when the person looks through the test lens at said physical target, some of the light reflecting from tissue in said eye such that said light propagates through an ocular lens and cornea of said eye and exits said eye;
measuring a wavefront of said reflected light emanating from the person's eye;
determining one or more values of a figure of merit using said wavefront measurement, said figure of merit indicative of quality of a person's vision; and
producing a graphic based on said one or more values of said figure of merit, said graphic indicative of the quality of a person's vision.
16. The method of claim 15, wherein said figure of merit comprises a function selected from the group consisting of a point spread function, a modulation transfer function, and an optical transfer function.
17. The method of claim 15, wherein said figure of merit is selected from the group consisting of (i) a sum of terms based on Zernike coefficients and (ii) a weighted sum of terms based on Zernike coefficients.
18. The method of claim 17, wherein said figure of merit includes a sum of squared Zernike coefficients.
19. The method of claim 15, wherein said figure of merit comprises a Quality of Vision Factor (QVF) defined as
QVF = - P n Z n 2
wherein Zn corresponds to coefficients for Zernike polynomials and Pn correspond to psychometric weight factors.
20. The method of claim 15, wherein said graphic is selected from the group consisting of a pie chart, a bar chart, and a line chart.
21. The apparatus of claim 15, wherein the graphic is color-coded in correspondence with said value of said figure of merit.
22. The method of claim 15, wherein said graphic comprises an image of said target convolved with a function derived from wavefront measurement, said graphic appearing more distorted with increasing aberration.
23. The method of claim 22, wherein said graphic comprises an image of said target convolved with a point spread function derived from wavefront measurement.
24. The method of claim 23, wherein said point spread function is derived by squaring the magnitude of the Fourier transform of the wavefront.
25. The method of claim 15, further comprising varying said test lens and determining said one or more figure of merit values for different lenses.
26. The method of claim 25, further comprising identifying the lens that provides an extreme value of said figure of merit corresponding to a maximal quality of vision.
27. The method of claim 26, wherein said extreme value comprises a peak average value of said figure of merit.
28. The method of claim 27, wherein said extreme value comprises a maximum point spread function.
29. The method of claim 15, further comprising directing said light through said test lens into said eye.
30. The method of claim 15, further comprising situating said test lens such that said light is directed into said eye without passing through said test lens.
31. A method of characterizing a person's vision, comprising:
(a) providing corrective optics for testing said vision, said corrective optics being variable to provide different amounts of optical correction;
(b) directing a light beam into an eye of the person, light from said light beam reflecting from tissue in said eye such that said light propagates through an ocular lens and cornea of said eye and exits said eye, said reflected light comprising a plurality of wavefronts;
(c) repetitively measuring said wavefronts emanating from the person's eye with said corrective optics adjusted to a substantially fixed amount of optical correction thereby producing a set of data points indicative of the quality of vision of the person for a given amount of optical correction; and
(d) determining the average and variation in said plurality of data points to provide an objective assessment of said correction.
32. The method of claim 31, wherein said determining the variation in said plurality of data points comprises determining the standard deviation.
33. The method of claim 31, further comprising comparing said variations and selecting an amount of optical correction based on said comparison.
34. The method of claim 33, wherein the optical correction is selected substantially equal to the amount yielding the least variation.
35. The method of claim 33, wherein the optical correction is selected substantially equal to the amount yielding the minimum standard deviation.
36. The method of claim 31, wherein said reflected light emanating from the person's eye is repetitively measured for an amount of optical correction such that the time period between the repeat measurements is sufficiently long to permit the eye to adjust its focus.
37. The method of claim 36, wherein said time period between repeat measurements ranges between about 0.1 to 5 seconds.
38. The method of claim 31, wherein said corrective optics comprises a plurality of test lens in a phoropter system.
39. The method of claim 31, wherein said corrective optics comprises an optical system having variable optical power.
40. The method of claim 31, further comprising selecting the amount of optical correction for said person based as least in part on the optical correction that yields reduced aberration in said wavefronts.
41. The method of claim 40, further comprising selecting the amount of optical power that provides a peak value of a figure of merit on the quality of vision of the patient.
42. The method of claim 31, wherein said optical correction selected is substantially equal to an amount between the optical correction yielding the least variation and the optical correction yielding the peak value of figure of merit on the quality of vision.
43. An apparatus for automatically determining correction for a patient's vision, said apparatus comprising:
test optics for testing said vision, said test optics being variable to provide different amounts of optical correction;
a light source and associated optics for directing light into an eye of the patient, said light reflecting from tissue in said eye, said reflected light comprising a plurality of wavefronts that propagate through an ocular lens and cornea in said eye;
a wavefront sensor including one or more optical detectors for measuring said wavefronts emanating from the patient's eye, said wavefront sensor having an electrical output representative of said wavefront;
an electrical processor configured to receive said electrical output from said wavefront sensor and determine the quality of said patient's vision therefrom; and
a mechanical actuator electrically connected to said processor, said mechanical actuator adjusting the test optics so as to vary the amounts of optical correction.
44. The apparatus of claim 43, further comprising a computer readable medium having a program of instructions stored thereon for causing said electrical processor to execute method steps for determining the quality of said patient's vision, comprising:
(a) calculating a value of a figure of merit indicative of the patient's quality of vision, said value being derived at least in part from a measurement of one of the wavefronts from the patient's eye;
(b) retrieving another wavefront measurement from the wavefront sensor;
(c) repeating steps (a) and (b) N times;
(c) calculating the average and variation of the figure of merit values and storing the average and variation as a data set for a given optical correction;
(d) instructing the actuator to alter the test optics to provide a different optical correction;
(e) repeating steps (a) through (d) until a predetermined end point has been reached; and
(f) selecting the optical correction that yields (i) the maximum average value of the figure of merit, (ii) the minimum variation of the figure of merit, or (iii) a value between those of (i) and (ii).
45. The apparatus of claim 43, further comprising a display electrically connected to said electrical processor so as to receive input from said electrical processor such that said electrical processor can output results of said measurements to said display.
46. The apparatus of claim 45, wherein said electrical processor and display are configured to provide a graphical representation of a target image as seen by the patient, said graphical representation generated by a convolution of said target image with a function derived from said wavefront measurements, said image being distorted an amount indicative of distortion in the patient's vision.
47. The apparatus of claim 45, wherein said electrical processor and display are configured to provide information selected from the group consisting of (1) a numerical and/or graphic representative of the effectiveness of application of different amount of optical power; and (2) a numerical and/or graphic display of the contrast function of the patient's vision.
48. The apparatus of claim 43, wherein said electrical processor includes electronic circuitry configured to select a prescription suitable for correction and an output for outputting said prescription.
49. The apparatus of claim 43, wherein said test optics comprise a plurality of test lens that can be separately introduced into an optical path between the patient's eye and a target to adjust the patient's vision.
50. A method of determining correction for a person's vision, comprising:
directing light into an eye of the person, said light reflecting from tissue in said eye, said reflected light comprising a plurality of wavefronts that propagates through an ocular lens and cornea in said eye;
measuring said wavefronts with a wavefront sensor;
representing at least one of said wavefronts by a sum of orthogonal components,

εKnQn,
where Qn corresponds to said orthogonal components and Kn corresponds to coefficients having values selected to substantially match said sum with said wavefront;
weighting said orthogonal components with psychometric weight factors Pn based on the relative influence of the orthogonal component Qn on human vision; and
designing optical correction based on said wavefront representation and said psychometric weight factors.
51. The method of claim 50, wherein said orthogonal components comprise Zernike polynomials.
52. The method of claim 50, wherein said psychometric weight factors Pn is obtained from a normative data base generated by quantifying the effects of the respective orthogonal components Qn in a normative population group.
53. A method of quantifying accommodation in an eye having a cornea, an ocular lens, and a retina, said method comprising:
directing a light beam into the eye, light from said light beam reflecting from tissue in said eye such that said light propagates through the ocular lens and cornea of said eye and exits said eye;
repetitively measuring wavefronts associated with said reflected light emanating from the eye for a set of conditions that induce an amount of accommodation, thereby producing a set of data points indicative of the quality of vision for said plurality of wavefronts measured under said set of conditions; and
determining the average and variation in said plurality of data points to provide a measurement of the amount of accommodation.
54. The method of claim 53, further comprising repeating said measuring and determining steps for different sets of conditions for inducing different amounts of accommodation, thereby producing a plurality of average values which if plotted form a curve having a maximum.
55. The method of claim 53, further comprising providing at least one target a distance from said eye.
56. The method of claim 55, wherein said first set of conditions includes a first target distance and said second set of conditions includes a second target distance, said first and second target distances being different so as to introduce different amounts of accommodation.
57. The method of claim 53, further comprising providing optics through which said eye can view at least one target, said optics having spherical power to move the image of the target behind the retina.
58. The method of claim 54, further comprising providing optics through which said eye can view at least one target, said optics having spherical power to move the image of the target behind the retina.
59. The method of claim 58, wherein said maximum is a plateau having a width, said method further comprising determining the accommodating power of a person from the width of the plateau in units of optical power.
60. The method of claim 53, wherein said determining the variation in said plurality of data points comprises determining the standard deviation from the data points.
61. A computer readable medium having a program of instructions stored thereon for causing an electrical processor to execute method steps for identifying optical correction for a person's eye based on wavefront measurements of light reflected from said person's eye, comprising:
(a) calculating a value of a figure of merit indicative of the person's quality of vision, said value being derived at least in part from a measurement of a wavefront from said person's eye;
(b) retrieving another wavefront measurement;
(c) repeating steps (a) and (b) N times;
(c) calculating the average and variation of the figure of merit values and storing the average and variation as a data set for a given optical correction;
(d) repeating steps (a) through (d) for different optical correction; and
(e) selecting the optical correction that yields (i) the maximum average value of the figure of merit, (ii) the minimum variation of the figure of merit, or (iii) a value between those of (i) and (ii).
62. The method of claim 41, the figure of merit on the quality of vision of the patient being selected from the group consisting of (a) QVF, defined as
QVF = - P n Z n 2
wherein Zn corresponds to coefficients for Zernike polynomials and Pn correspond to psychometric weight factors, (b) a point spread function, and (c) a sum of squared Zernike coefficients.
US10/653,552 2002-02-13 2003-09-02 Apparatus and method for determining subjective responses using objective characterization of vision based on wavefront sensing Abandoned US20050174535A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US10/653,552 US20050174535A1 (en) 2003-02-13 2003-09-02 Apparatus and method for determining subjective responses using objective characterization of vision based on wavefront sensing
US11/652,856 US7490940B2 (en) 2002-02-13 2007-01-12 Method for determining objective refraction using wavefront sensing
US12/350,813 US20090161070A1 (en) 2002-02-13 2009-01-08 Apparatus and method for determining objective refraction using wavefront sensing

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2003/004921 WO2003068059A2 (en) 2002-02-13 2003-02-13 Apparatus and method for objective characterization of vision based on wavefront sensing
US10/653,552 US20050174535A1 (en) 2003-02-13 2003-09-02 Apparatus and method for determining subjective responses using objective characterization of vision based on wavefront sensing

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/004921 Continuation WO2003068059A2 (en) 2002-02-13 2003-02-13 Apparatus and method for objective characterization of vision based on wavefront sensing

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/652,856 Continuation US7490940B2 (en) 2002-02-13 2007-01-12 Method for determining objective refraction using wavefront sensing

Publications (1)

Publication Number Publication Date
US20050174535A1 true US20050174535A1 (en) 2005-08-11

Family

ID=34826311

Family Applications (3)

Application Number Title Priority Date Filing Date
US10/653,552 Abandoned US20050174535A1 (en) 2002-02-13 2003-09-02 Apparatus and method for determining subjective responses using objective characterization of vision based on wavefront sensing
US11/652,856 Expired - Lifetime US7490940B2 (en) 2002-02-13 2007-01-12 Method for determining objective refraction using wavefront sensing
US12/350,813 Abandoned US20090161070A1 (en) 2002-02-13 2009-01-08 Apparatus and method for determining objective refraction using wavefront sensing

Family Applications After (2)

Application Number Title Priority Date Filing Date
US11/652,856 Expired - Lifetime US7490940B2 (en) 2002-02-13 2007-01-12 Method for determining objective refraction using wavefront sensing
US12/350,813 Abandoned US20090161070A1 (en) 2002-02-13 2009-01-08 Apparatus and method for determining objective refraction using wavefront sensing

Country Status (1)

Country Link
US (3) US20050174535A1 (en)

Cited By (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050225724A1 (en) * 2004-03-31 2005-10-13 Nidek Co., Ltd. Corneal topography analysis system
US20070195264A1 (en) * 2006-02-14 2007-08-23 Lai Shui T Subjective Refraction Method and Device for Correcting Low and Higher Order Aberrations
US20070258046A1 (en) * 2006-02-14 2007-11-08 Lai Shui T Subjective Wavefront Refraction Using Continuously Adjustable Wave Plates of Zernike Function
US20080037135A1 (en) * 2006-07-25 2008-02-14 Lai Shui T Method of Making High Precision Optics Having a Wavefront Profile
US20080100800A1 (en) * 2006-10-25 2008-05-01 Carl Zeiss Vision Gmbh Eyeglass prescription method
US20080152198A1 (en) * 2004-08-03 2008-06-26 Shinichi Tsukahara Biometric Identification Device, Authentication Device Using Same, and Biometric Identification Method
US20080192204A1 (en) * 2005-06-03 2008-08-14 Hospital Sant Joan De Deu Eye Movement Sensor Device
US20080284979A1 (en) * 2007-05-17 2008-11-20 Visx, Incorporated System and Method for Illumination and Fixation with Ophthalmic Diagnostic Instruments
US20090015787A1 (en) * 2007-07-09 2009-01-15 Carl Zeiss Vision Gmbh Apparatus and method for determining an eyeglass prescription for a vision defect of an eye
US20090152453A1 (en) * 2005-12-13 2009-06-18 Agency For Science, Technology And Research Optical wavefront sensor
US20110194067A1 (en) * 2007-10-31 2011-08-11 Hoya Corporation Spectacle lens evaluating method, spectacle lens designing method using same, spectacle lens manufacturing method, spectacle lens manufacturing system, and spectacle lens
US20110202421A1 (en) * 2007-10-31 2011-08-18 Hoya Corporation Spectacle lens evaluating method, spectacle lens designing method using same, spectacle lens manufacturing method, spectacle lens manufacturing system, and spectacle lens
US20110213462A1 (en) * 2007-08-02 2011-09-01 Elenza, Inc. Multi-Focal Intraocular Lens System and Methods
WO2012068312A1 (en) * 2010-11-17 2012-05-24 Lai Shui T Self guided subjective refraction instruments and methods
US20120127432A1 (en) * 2010-11-16 2012-05-24 University Of Rochester Measuring ocular point spread function using adaptive optics
US20130201474A1 (en) * 2012-02-07 2013-08-08 Bausch & Lomb Incorporated Aberrometer for Measuring Parameters of a Lens Using Multiple Point Sources of Light
US20130222765A1 (en) * 2012-02-13 2013-08-29 Digitalvision, Llc Contact lens optimizer
WO2014177179A1 (en) * 2013-04-29 2014-11-06 Carl Zeiss Vision International Gmbh Method and system for determining the refractive properties of an eye of a child
EP2809220A1 (en) * 2012-02-03 2014-12-10 DigitalVision LLC A refractometer with a comparative vision correction simulator
US20140375789A1 (en) * 2013-06-25 2014-12-25 Xinye Lou Eye-tracking system for head-mounted display
US8934166B2 (en) 2011-12-29 2015-01-13 Elwha Llc Customized user options for optical device
US8950865B2 (en) 2010-11-16 2015-02-10 Shui T Lai Effective acuity and refraction targets
US9033497B2 (en) 2011-12-29 2015-05-19 Elwha Llc Optical device with interchangeable corrective elements
US9046683B2 (en) 2011-12-29 2015-06-02 Elwha Llc Adjustable optics for ongoing viewing correction
US20150230704A1 (en) * 2012-11-09 2015-08-20 Canon Kabushiki Kaisha Adaptive optical apparatus and ophthalmic apparatus
CN105473056A (en) * 2013-07-02 2016-04-06 麻省理工学院 Apparatus and method of determining an eye prescription
EP2926193A4 (en) * 2012-11-28 2016-06-01 Perfect Vision Technology Ltd Methods and systems for automated measurement of the eyes and delivering of sunglasses and eyeglasses
US9649032B2 (en) 2008-12-01 2017-05-16 Perfect Vision Technology (Hk) Ltd. Systems and methods for remote measurement of the eyes and delivering of sunglasses and eyeglasses
US9826899B2 (en) 2008-12-01 2017-11-28 Perfect Vision Technology (Hk) Ltd. Methods and devices for refractive correction of eyes
US20180252927A1 (en) * 2015-10-02 2018-09-06 Crewt Medical Systems, Inc. Head-mounted display unit and head-mounted display fixing stand
US20180286125A1 (en) * 2017-03-31 2018-10-04 Cae Inc. Deteriorated video feed
US10228561B2 (en) 2013-06-25 2019-03-12 Microsoft Technology Licensing, Llc Eye-tracking system using a freeform prism and gaze-detection light
EP3888525A1 (en) * 2020-03-31 2021-10-06 Universitat Politècnica De Catalunya Method and computer programs to characterize eye accommodation

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7556378B1 (en) 2003-04-10 2009-07-07 Tsontcho Ianchulev Intraoperative estimation of intraocular lens power
CA2561388C (en) 2004-04-20 2017-10-10 Wavetec Vision Systems, Inc. Integrated surgical microscope and wavefront sensor
US7594729B2 (en) 2007-10-31 2009-09-29 Wf Systems, Llc Wavefront sensor
US8007103B2 (en) * 2008-08-15 2011-08-30 Carl Zeiss Vision Gmbh System and method for prescription of visual aids
WO2010054268A2 (en) 2008-11-06 2010-05-14 Wavetec Vision Systems, Inc. Optical angular measurement system for ophthalmic applications and method for positioning of a toric intraocular lens with increased accuracy
US20150290032A1 (en) * 2009-04-06 2015-10-15 Amo Development, Llc Manifest refraction treatment systems and methods
WO2013013175A1 (en) 2011-07-20 2013-01-24 Amo Development, Llc. Manifest refraction treatment systems and methods
US8876290B2 (en) 2009-07-06 2014-11-04 Wavetec Vision Systems, Inc. Objective quality metric for ocular wavefront measurements
WO2011008609A1 (en) 2009-07-14 2011-01-20 Wavetec Vision Systems, Inc. Ophthalmic surgery measurement system
WO2011008606A1 (en) * 2009-07-14 2011-01-20 Wavetec Vision Systems, Inc. Determination of the effective lens position of an intraocular lens using aphakic refractive power
US9237846B2 (en) 2011-02-17 2016-01-19 Welch Allyn, Inc. Photorefraction ocular screening device and methods
US9072462B2 (en) 2012-09-27 2015-07-07 Wavetec Vision Systems, Inc. Geometric optical power measurement device
CN103487239B (en) * 2013-10-11 2015-11-25 杭州奥普特光学有限公司 Hand-held eyeglass surface focal power measurement device
EP3291722A4 (en) * 2015-05-05 2019-03-27 Visionix Ltd. Improved objective phoropter
WO2016207684A1 (en) * 2015-06-23 2016-12-29 Essilor International (Compagnie Generale D'optique) Optometry measuring scale
US10506165B2 (en) 2015-10-29 2019-12-10 Welch Allyn, Inc. Concussion screening system
CN107125993B (en) * 2017-03-29 2020-06-30 柳州市昌泉贸易有限公司 Seat system for vision detection
US11234588B2 (en) 2018-04-09 2022-02-01 Shui T Lai Concise representation for review of a subjective refraction test

Citations (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105302A (en) * 1976-06-23 1978-08-08 Tate Jr George W Automatic refraction apparatus and method
US4711576A (en) * 1985-02-04 1987-12-08 Canon Kabushiki Kaisha Wave front aberration measuring apparatus
US5062702A (en) * 1990-03-16 1991-11-05 Intelligent Surgical Lasers, Inc. Device for mapping corneal topography
US5080477A (en) * 1989-08-28 1992-01-14 Yoshi Adachi Surface topographer
US5164750A (en) * 1990-11-08 1992-11-17 Yoshi Adachi Aspheric surface topographer
US5528321A (en) * 1992-11-23 1996-06-18 Innotech, Inc. Method of manufacturing contact lenses
US5777719A (en) * 1996-12-23 1998-07-07 University Of Rochester Method and apparatus for improving vision and the resolution of retinal images
US5929970A (en) * 1997-05-13 1999-07-27 Kabushiki Kaisha Topcon Optical characteristic measuring apparatus
US5963300A (en) * 1998-02-17 1999-10-05 Amt Technologies, Corp. Ocular biometer
US6007204A (en) * 1998-06-03 1999-12-28 Welch Allyn, Inc. Compact ocular measuring system
US6050687A (en) * 1999-06-11 2000-04-18 20/10 Perfect Vision Optische Geraete Gmbh Method and apparatus for measurement of the refractive properties of the human eye
US6086204A (en) * 1999-09-20 2000-07-11 Magnante; Peter C. Methods and devices to design and fabricate surfaces on contact lenses and on corneal tissue that correct the eye's optical aberrations
US6112114A (en) * 1991-12-16 2000-08-29 Laser Diagnostic Technologies, Inc. Eye examination apparatus employing polarized light probe
US6120150A (en) * 1997-04-24 2000-09-19 Orbtek, Inc. Device and method for mapping the topography of an eye using elevation measurements in combination with slope measurements
US6199986B1 (en) * 1999-10-21 2001-03-13 University Of Rochester Rapid, automatic measurement of the eye's wave aberration
US6234631B1 (en) * 2000-03-09 2001-05-22 Lasersight Technologies, Inc. Combination advanced corneal topography/wave front aberration measurement
US6256098B1 (en) * 1998-11-23 2001-07-03 Inray Ltd. Method for determining and designing optical elements
US6270221B1 (en) * 1998-08-19 2001-08-07 Alcon Universal Ltd. Apparatus and method for measuring vision defects of a human eye
US6271915B1 (en) * 1996-11-25 2001-08-07 Autonomous Technologies Corporation Objective measurement and correction of optical systems using wavefront analysis
US6305802B1 (en) * 1999-08-11 2001-10-23 Johnson & Johnson Vision Products, Inc. System and method of integrating corneal topographic data and ocular wavefront data with primary ametropia measurements to create a soft contact lens design
US6309068B1 (en) * 1997-08-05 2001-10-30 Canon Kabushiki Kaisha Eye examining apparatus
US20010035939A1 (en) * 2000-03-28 2001-11-01 Toshifumi Mihashi Eye characteristic measuring apparatus
US20010041884A1 (en) * 1996-11-25 2001-11-15 Frey Rudolph W. Method for determining and correcting vision
US6338559B1 (en) * 2000-04-28 2002-01-15 University Of Rochester Apparatus and method for improving vision and retinal imaging
US20020047992A1 (en) * 2000-01-27 2002-04-25 Zyoptics, Inc. Method and apparatus for measuring optical aberrations of the human eye
US6379008B1 (en) * 1999-09-22 2002-04-30 Essilor International (Compagnie Generale D'optique) Method of determining the shape of an opthalmic contact lens for correcting optical aberrations of the eye beyond defocusing or astigmatism and system for implementing the method
US6382795B1 (en) * 2000-05-20 2002-05-07 Carl Zeiss, Inc. Method and apparatus for measuring refractive errors of an eye
US6394605B1 (en) * 2001-05-23 2002-05-28 Alcon Universal Ltd. Fogging method for a wavefront sensor
US6396588B1 (en) * 1999-10-06 2002-05-28 Trw Inc. Hybrid curvature-tilt wave front sensor
US20020122153A1 (en) * 2000-12-22 2002-09-05 Piers Patricia Ann Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US20020140902A1 (en) * 2000-10-10 2002-10-03 University Of Rochester Determination of ocular refraction from wavefront aberration data and design of optimum customized correction
US6460997B1 (en) * 2000-05-08 2002-10-08 Alcon Universal Ltd. Apparatus and method for objective measurements of optical systems using wavefront analysis
US20020167643A1 (en) * 2001-04-18 2002-11-14 Gerhard Youssefi Objective manifest refraction
US20020186346A1 (en) * 2000-10-20 2002-12-12 Keith Stantz Method for computing visual performance from objective ocular aberration measurements
US20020196412A1 (en) * 2001-05-31 2002-12-26 Marc Abitbol Aberration correction spectacle lens
US6499843B1 (en) * 2000-09-13 2002-12-31 Bausch & Lomb Incorporated Customized vision correction method and business
US20030011745A1 (en) * 1998-10-07 2003-01-16 Tracey Technologies, Llc Device for measuring aberration refraction of the eye
US6547392B2 (en) * 2000-03-30 2003-04-15 Nidek Co., Ltd. Ophthalmic apparatus
US6550917B1 (en) * 2000-02-11 2003-04-22 Wavefront Sciences, Inc. Dynamic range extension techniques for a wavefront sensor including use in ophthalmic measurement
US20030076478A1 (en) * 2001-10-19 2003-04-24 Bausch & Lomb Incorporated Presbyopic vision improvement
US6554429B1 (en) * 2001-10-15 2003-04-29 Alcon, Inc. Method for determining accommodation
US20030151721A1 (en) * 2002-02-13 2003-08-14 Lai Shui T. Apparatus and method for determining objective refraction using wavefront sensing
US20030210378A1 (en) * 2002-01-17 2003-11-13 Riza Nabeel Agha Optoelectronic eye examination system
US20040169820A1 (en) * 2002-12-06 2004-09-02 Visx, Incorporated Presbyopia correction using patient data
US6802605B2 (en) * 2001-12-11 2004-10-12 Bausch And Lomb, Inc. Contact lens and method for fitting and design

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992001417A1 (en) 1990-07-19 1992-02-06 Horwitz Larry S Vision measurement and correction
DE4222395A1 (en) 1992-07-08 1994-01-13 Amtech Ges Fuer Angewandte Mic Optical system for measuring refraction of eye with light source - has variable imaging optics adjustable in its power of refraction focussing light emanating from light source on retina of eye
UA46833C2 (en) 1998-10-07 2002-06-17 Інститут Біомедичної Техніки Та Технологій Академії Технологічних Наук України EYE ABERATIONAL REFRACTION MEASURING INSTRUMENT
CN1423546A (en) 1999-12-29 2003-06-11 新英格兰验光学院 Myopia progression retardation by optical defect correction
JP4459501B2 (en) 2000-05-23 2010-04-28 エイ・エム・オー・フローニンゲン・ベー・ベー Eye lens to reduce eye aberration
IL137635A0 (en) 2000-08-01 2001-10-31 Visionix Ltd Apparatus for interactive optometry
NL1015935C2 (en) 2000-08-15 2002-02-18 Stichting Tech Wetenschapp Method for determining the quality of an eye optic.
US6616279B1 (en) 2000-10-02 2003-09-09 Johnson & Johnson Vision Care, Inc. Method and apparatus for measuring wavefront aberrations
US7311400B2 (en) * 2001-04-16 2007-12-25 Tracey Technologies, Llc Determining clinical refraction of eye
CA2455454A1 (en) 2001-07-27 2003-02-06 Tracey Technologies, Llc Measuring refractive characteristics of human eyes

Patent Citations (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105302A (en) * 1976-06-23 1978-08-08 Tate Jr George W Automatic refraction apparatus and method
US4711576A (en) * 1985-02-04 1987-12-08 Canon Kabushiki Kaisha Wave front aberration measuring apparatus
US5080477A (en) * 1989-08-28 1992-01-14 Yoshi Adachi Surface topographer
US5062702A (en) * 1990-03-16 1991-11-05 Intelligent Surgical Lasers, Inc. Device for mapping corneal topography
US5164750A (en) * 1990-11-08 1992-11-17 Yoshi Adachi Aspheric surface topographer
US6112114A (en) * 1991-12-16 2000-08-29 Laser Diagnostic Technologies, Inc. Eye examination apparatus employing polarized light probe
US5528321A (en) * 1992-11-23 1996-06-18 Innotech, Inc. Method of manufacturing contact lenses
US6271915B1 (en) * 1996-11-25 2001-08-07 Autonomous Technologies Corporation Objective measurement and correction of optical systems using wavefront analysis
US20010041884A1 (en) * 1996-11-25 2001-11-15 Frey Rudolph W. Method for determining and correcting vision
US5777719A (en) * 1996-12-23 1998-07-07 University Of Rochester Method and apparatus for improving vision and the resolution of retinal images
US6379005B1 (en) * 1996-12-23 2002-04-30 University Of Rochester Method and apparatus for improving vision and the resolution of retinal images
US5949521A (en) * 1996-12-23 1999-09-07 University Of Rochester Method and apparatus for improving vision and the resolution of retinal images
US6095651A (en) * 1996-12-23 2000-08-01 University Of Rochester Method and apparatus for improving vision and the resolution of retinal images
US6120150A (en) * 1997-04-24 2000-09-19 Orbtek, Inc. Device and method for mapping the topography of an eye using elevation measurements in combination with slope measurements
US6257723B1 (en) * 1997-04-24 2001-07-10 Bausch & Lomb Surgical, Inc. Device and method for mapping the topography of an eye using elevation measurements in combination with slope measurements
US5929970A (en) * 1997-05-13 1999-07-27 Kabushiki Kaisha Topcon Optical characteristic measuring apparatus
US6309068B1 (en) * 1997-08-05 2001-10-30 Canon Kabushiki Kaisha Eye examining apparatus
US5963300A (en) * 1998-02-17 1999-10-05 Amt Technologies, Corp. Ocular biometer
US6007204A (en) * 1998-06-03 1999-12-28 Welch Allyn, Inc. Compact ocular measuring system
US6270221B1 (en) * 1998-08-19 2001-08-07 Alcon Universal Ltd. Apparatus and method for measuring vision defects of a human eye
US20030011745A1 (en) * 1998-10-07 2003-01-16 Tracey Technologies, Llc Device for measuring aberration refraction of the eye
US6256098B1 (en) * 1998-11-23 2001-07-03 Inray Ltd. Method for determining and designing optical elements
US6155684A (en) * 1999-06-11 2000-12-05 Perfect Vision Optische Geraete Gmbh Method and apparatus for precompensating the refractive properties of the human eye with adaptive optical feedback control
US6050687A (en) * 1999-06-11 2000-04-18 20/10 Perfect Vision Optische Geraete Gmbh Method and apparatus for measurement of the refractive properties of the human eye
US6305802B1 (en) * 1999-08-11 2001-10-23 Johnson & Johnson Vision Products, Inc. System and method of integrating corneal topographic data and ocular wavefront data with primary ametropia measurements to create a soft contact lens design
US6086204A (en) * 1999-09-20 2000-07-11 Magnante; Peter C. Methods and devices to design and fabricate surfaces on contact lenses and on corneal tissue that correct the eye's optical aberrations
US6379008B1 (en) * 1999-09-22 2002-04-30 Essilor International (Compagnie Generale D'optique) Method of determining the shape of an opthalmic contact lens for correcting optical aberrations of the eye beyond defocusing or astigmatism and system for implementing the method
US6396588B1 (en) * 1999-10-06 2002-05-28 Trw Inc. Hybrid curvature-tilt wave front sensor
US6299311B1 (en) * 1999-10-21 2001-10-09 University Of Rochester Rapid, automatic measurement of the eye's wave aberration
US6199986B1 (en) * 1999-10-21 2001-03-13 University Of Rochester Rapid, automatic measurement of the eye's wave aberration
US20020047992A1 (en) * 2000-01-27 2002-04-25 Zyoptics, Inc. Method and apparatus for measuring optical aberrations of the human eye
US6550917B1 (en) * 2000-02-11 2003-04-22 Wavefront Sciences, Inc. Dynamic range extension techniques for a wavefront sensor including use in ophthalmic measurement
US20010033362A1 (en) * 2000-03-09 2001-10-25 Sarver Edwin J. Combination advanced corneal topography/wave front aberration measurement
US6234631B1 (en) * 2000-03-09 2001-05-22 Lasersight Technologies, Inc. Combination advanced corneal topography/wave front aberration measurement
US20010035939A1 (en) * 2000-03-28 2001-11-01 Toshifumi Mihashi Eye characteristic measuring apparatus
US6547392B2 (en) * 2000-03-30 2003-04-15 Nidek Co., Ltd. Ophthalmic apparatus
US6338559B1 (en) * 2000-04-28 2002-01-15 University Of Rochester Apparatus and method for improving vision and retinal imaging
US6460997B1 (en) * 2000-05-08 2002-10-08 Alcon Universal Ltd. Apparatus and method for objective measurements of optical systems using wavefront analysis
US6382795B1 (en) * 2000-05-20 2002-05-07 Carl Zeiss, Inc. Method and apparatus for measuring refractive errors of an eye
US6499843B1 (en) * 2000-09-13 2002-12-31 Bausch & Lomb Incorporated Customized vision correction method and business
US6511180B2 (en) * 2000-10-10 2003-01-28 University Of Rochester Determination of ocular refraction from wavefront aberration data and design of optimum customized correction
US20020140902A1 (en) * 2000-10-10 2002-10-03 University Of Rochester Determination of ocular refraction from wavefront aberration data and design of optimum customized correction
US6607274B2 (en) * 2000-10-20 2003-08-19 Wavefront Sciences, Inc. Method for computing visual performance from objective ocular aberration measurements
US20020186346A1 (en) * 2000-10-20 2002-12-12 Keith Stantz Method for computing visual performance from objective ocular aberration measurements
US20020122153A1 (en) * 2000-12-22 2002-09-05 Piers Patricia Ann Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US20020167643A1 (en) * 2001-04-18 2002-11-14 Gerhard Youssefi Objective manifest refraction
US6394605B1 (en) * 2001-05-23 2002-05-28 Alcon Universal Ltd. Fogging method for a wavefront sensor
US20020196412A1 (en) * 2001-05-31 2002-12-26 Marc Abitbol Aberration correction spectacle lens
US6554429B1 (en) * 2001-10-15 2003-04-29 Alcon, Inc. Method for determining accommodation
US6679606B2 (en) * 2001-10-15 2004-01-20 Alcon, Inc. Method for determining accommodation
US20030076478A1 (en) * 2001-10-19 2003-04-24 Bausch & Lomb Incorporated Presbyopic vision improvement
US6802605B2 (en) * 2001-12-11 2004-10-12 Bausch And Lomb, Inc. Contact lens and method for fitting and design
US20030210378A1 (en) * 2002-01-17 2003-11-13 Riza Nabeel Agha Optoelectronic eye examination system
US20030151721A1 (en) * 2002-02-13 2003-08-14 Lai Shui T. Apparatus and method for determining objective refraction using wavefront sensing
US20040169820A1 (en) * 2002-12-06 2004-09-02 Visx, Incorporated Presbyopia correction using patient data

Cited By (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7370969B2 (en) * 2004-03-31 2008-05-13 Nidek Co., Ltd. Corneal topography analysis system
US20050225724A1 (en) * 2004-03-31 2005-10-13 Nidek Co., Ltd. Corneal topography analysis system
US20080152198A1 (en) * 2004-08-03 2008-06-26 Shinichi Tsukahara Biometric Identification Device, Authentication Device Using Same, and Biometric Identification Method
US7931370B2 (en) * 2005-06-03 2011-04-26 Hospital Sant Joan De Deu Eye movement sensor device
US20080192204A1 (en) * 2005-06-03 2008-08-14 Hospital Sant Joan De Deu Eye Movement Sensor Device
US20090152453A1 (en) * 2005-12-13 2009-06-18 Agency For Science, Technology And Research Optical wavefront sensor
US8158917B2 (en) * 2005-12-13 2012-04-17 Agency For Science Technology And Research Optical wavefront sensor and optical wavefront sensing method
US20120169998A1 (en) * 2006-02-14 2012-07-05 Lai Shui T Subjective wavefront refraction using continuously adjustable wave plates of zernike function
US10383512B2 (en) 2006-02-14 2019-08-20 Shui T. Lai Subjective wavefront refraction using continuously adjustable wave plates of Zernike function
US7699471B2 (en) 2006-02-14 2010-04-20 Lai Shui T Subjective refraction method and device for correcting low and higher order aberrations
US7726811B2 (en) 2006-02-14 2010-06-01 Lai Shui T Subjective wavefront refraction using continuously adjustable wave plates of Zernike function
US20070258046A1 (en) * 2006-02-14 2007-11-08 Lai Shui T Subjective Wavefront Refraction Using Continuously Adjustable Wave Plates of Zernike Function
US9320426B2 (en) * 2006-02-14 2016-04-26 Shui T. Lai Subjective wavefront refraction using continuously adjustable wave plates of zernike function
US20070195264A1 (en) * 2006-02-14 2007-08-23 Lai Shui T Subjective Refraction Method and Device for Correcting Low and Higher Order Aberrations
US20080037135A1 (en) * 2006-07-25 2008-02-14 Lai Shui T Method of Making High Precision Optics Having a Wavefront Profile
US7959284B2 (en) 2006-07-25 2011-06-14 Lai Shui T Method of making high precision optics having a wavefront profile
US20080231802A2 (en) * 2006-10-25 2008-09-25 Carl Zeiss Vision Gmbh Eyeglass prescription method
US20080100800A1 (en) * 2006-10-25 2008-05-01 Carl Zeiss Vision Gmbh Eyeglass prescription method
US9055890B2 (en) 2006-10-25 2015-06-16 Carl Zeiss Vision Gmbh Eyeglass prescription method
US8079707B2 (en) 2006-10-25 2011-12-20 Carl Zeiss Vision Gmbh Eyeglass prescription method
WO2008144168A3 (en) * 2007-05-17 2009-01-22 Amo Dev Llc System and method for illumination and fixation with ophthalmic diagnostic instruments
US8016420B2 (en) 2007-05-17 2011-09-13 Amo Development Llc. System and method for illumination and fixation with ophthalmic diagnostic instruments
US20080284979A1 (en) * 2007-05-17 2008-11-20 Visx, Incorporated System and Method for Illumination and Fixation with Ophthalmic Diagnostic Instruments
US8833940B2 (en) 2007-05-17 2014-09-16 Amo Manufacturing Usa, Llc System and method for illumination and fixation with ophthalmic diagnostic instruments
US7744217B2 (en) * 2007-07-09 2010-06-29 Carl Zeiss Vision Gmbh Apparatus and method for determining an eyeglass prescription for a vision defect of an eye
US20090015787A1 (en) * 2007-07-09 2009-01-15 Carl Zeiss Vision Gmbh Apparatus and method for determining an eyeglass prescription for a vision defect of an eye
US20110213462A1 (en) * 2007-08-02 2011-09-01 Elenza, Inc. Multi-Focal Intraocular Lens System and Methods
US8384002B2 (en) * 2007-08-02 2013-02-26 Elenza, Inc. Multi-focal intraocular lens system and methods
US9066796B2 (en) 2007-08-02 2015-06-30 Elenza, Inc. Multi-focal intraocular lens system and methods for dynamic visual environments
US20110202421A1 (en) * 2007-10-31 2011-08-18 Hoya Corporation Spectacle lens evaluating method, spectacle lens designing method using same, spectacle lens manufacturing method, spectacle lens manufacturing system, and spectacle lens
US8393732B2 (en) 2007-10-31 2013-03-12 Hoya Corporation Spectacle lens evaluating method, spectacle lens designing method using same, spectacle lens manufacturing method, spectacle lens manufacturing system, and spectacle lens
US8474975B2 (en) 2007-10-31 2013-07-02 Hoya Corporation Spectacle lens evaluating method, spectacle lens designing method using same, spectacle lens manufacturing method, spectacle lens manufacturing system, and spectacle lens
US8226230B2 (en) 2007-10-31 2012-07-24 Hoya Corporation Spectacle lens evaluating method, spectacle lens designing method using same, spectacle lens manufacturing method, spectacle lens manufacturing system, and spectacle lens
US20110194067A1 (en) * 2007-10-31 2011-08-11 Hoya Corporation Spectacle lens evaluating method, spectacle lens designing method using same, spectacle lens manufacturing method, spectacle lens manufacturing system, and spectacle lens
EP3269296A1 (en) * 2008-12-01 2018-01-17 Perfect Vision Technology (HK) Ltd. Methods and devices for refractive correction of eyes
US9826899B2 (en) 2008-12-01 2017-11-28 Perfect Vision Technology (Hk) Ltd. Methods and devices for refractive correction of eyes
US9649032B2 (en) 2008-12-01 2017-05-16 Perfect Vision Technology (Hk) Ltd. Systems and methods for remote measurement of the eyes and delivering of sunglasses and eyeglasses
US10194796B2 (en) 2010-11-16 2019-02-05 Shui T Lai Effective acuity and refraction targets
US9743829B2 (en) 2010-11-16 2017-08-29 Shui T. Lai Effective acuity and refraction targets
US20120127432A1 (en) * 2010-11-16 2012-05-24 University Of Rochester Measuring ocular point spread function using adaptive optics
US8950865B2 (en) 2010-11-16 2015-02-10 Shui T Lai Effective acuity and refraction targets
US9247871B2 (en) 2010-11-16 2016-02-02 Shui T Lai Effective acuity and refraction targets
US8616703B2 (en) * 2010-11-16 2013-12-31 University Of Rochester Measuring ocular point spread function using adaptive optics
US9730578B2 (en) 2010-11-17 2017-08-15 Shui T Lai Self guided subjective refraction instruments and methods
US9408533B2 (en) 2010-11-17 2016-08-09 Shui T Lai Self guided subjective refraction instruments and methods
US8967801B2 (en) 2010-11-17 2015-03-03 Shui T Lai Self guided subjective refraction instruments and methods
WO2012068312A1 (en) * 2010-11-17 2012-05-24 Lai Shui T Self guided subjective refraction instruments and methods
US10194794B2 (en) 2010-11-17 2019-02-05 Shui T Lai Self guided subjective refraction instruments and methods
US8632184B2 (en) 2010-11-17 2014-01-21 Shui T. Lai Self guided subjective refraction instruments and methods
US9046683B2 (en) 2011-12-29 2015-06-02 Elwha Llc Adjustable optics for ongoing viewing correction
US9052502B2 (en) 2011-12-29 2015-06-09 Elwha Llc Corrective alignment optics for optical device
US9033497B2 (en) 2011-12-29 2015-05-19 Elwha Llc Optical device with interchangeable corrective elements
US8934166B2 (en) 2011-12-29 2015-01-13 Elwha Llc Customized user options for optical device
EP2809220A4 (en) * 2012-02-03 2015-04-08 Digitalvision Llc A refractometer with a comparative vision correction simulator
EP2809220A1 (en) * 2012-02-03 2014-12-10 DigitalVision LLC A refractometer with a comparative vision correction simulator
US20130201474A1 (en) * 2012-02-07 2013-08-08 Bausch & Lomb Incorporated Aberrometer for Measuring Parameters of a Lens Using Multiple Point Sources of Light
CN104470418A (en) * 2012-02-13 2015-03-25 迪吉塔尔视觉有限责任公司 Contact lens optimizer
US20130222765A1 (en) * 2012-02-13 2013-08-29 Digitalvision, Llc Contact lens optimizer
US9918631B2 (en) * 2012-11-09 2018-03-20 Canon Kabushiki Kaisha Adaptive optical apparatus and ophthalmic apparatus
US20150230704A1 (en) * 2012-11-09 2015-08-20 Canon Kabushiki Kaisha Adaptive optical apparatus and ophthalmic apparatus
EP2926193A4 (en) * 2012-11-28 2016-06-01 Perfect Vision Technology Ltd Methods and systems for automated measurement of the eyes and delivering of sunglasses and eyeglasses
KR101773697B1 (en) * 2013-04-29 2017-08-31 칼 자이스 비전 인터내셔널 게엠베하 Method and system for determining the refractive properties of an eye of a child
WO2014177179A1 (en) * 2013-04-29 2014-11-06 Carl Zeiss Vision International Gmbh Method and system for determining the refractive properties of an eye of a child
AU2013388426B2 (en) * 2013-04-29 2017-10-12 Carl Zeiss Vision International Gmbh Method and system for determining the refractive properties of an eye of a child
KR101789972B1 (en) * 2013-04-29 2017-10-25 칼 자이스 비전 인터내셔널 게엠베하 Method and system for determining the refractive properties of an eye of a child
US10881292B2 (en) 2013-04-29 2021-01-05 Carl Zeiss Vision International Gmbh Method and system for determining the refractive properties of an eye of a child
EP3692890A1 (en) * 2013-04-29 2020-08-12 Carl Zeiss Vision International GmbH Method and system for determining the refractive properties of an eye of a child
CN105611869A (en) * 2013-04-29 2016-05-25 卡尔蔡司光学国际有限公司 Method and system for determining the refractive properties of an eye of a child
AU2017235932B2 (en) * 2013-04-29 2019-05-09 Carl Zeiss Vision International Gmbh Method and system for determining the refractive properties of an eye of a child
US10228561B2 (en) 2013-06-25 2019-03-12 Microsoft Technology Licensing, Llc Eye-tracking system using a freeform prism and gaze-detection light
US9625723B2 (en) * 2013-06-25 2017-04-18 Microsoft Technology Licensing, Llc Eye-tracking system using a freeform prism
US20140375789A1 (en) * 2013-06-25 2014-12-25 Xinye Lou Eye-tracking system for head-mounted display
US10349830B2 (en) 2013-07-02 2019-07-16 Massachusetts Institute Of Technology Apparatus and method of determining an eye prescription
US20160128562A1 (en) * 2013-07-02 2016-05-12 Massachusetts Institute Of Technology Apparatus and Method of Determining an Eye Prescription
CN105578947A (en) * 2013-07-02 2016-05-11 麻省理工学院 Apparatus and method of determining an eye prescription
JP2016526985A (en) * 2013-07-02 2016-09-08 マサチューセッツ インスティテュート オブ テクノロジー Apparatus and method for determining ophthalmic prescription
CN105473056A (en) * 2013-07-02 2016-04-06 麻省理工学院 Apparatus and method of determining an eye prescription
US9854965B2 (en) 2013-07-02 2018-01-02 Massachusetts Institute Of Technology Apparatus and method of determining an eye prescription
US10786150B2 (en) 2013-07-02 2020-09-29 Massachusetts Institute Of Technology Apparatus and method of determining an eye prescription
EP3016576A4 (en) * 2013-07-02 2017-01-18 Massachusetts Institute of Technology Apparatus and method of determining an eye prescription
US20180252927A1 (en) * 2015-10-02 2018-09-06 Crewt Medical Systems, Inc. Head-mounted display unit and head-mounted display fixing stand
US10564432B2 (en) * 2015-10-02 2020-02-18 Crewt Medical Systems, Inc. Head-mounted display unit and head-mounted display fixing stand
US20180286125A1 (en) * 2017-03-31 2018-10-04 Cae Inc. Deteriorated video feed
EP3888525A1 (en) * 2020-03-31 2021-10-06 Universitat Politècnica De Catalunya Method and computer programs to characterize eye accommodation
WO2021197874A1 (en) 2020-03-31 2021-10-07 Universitat Politecnica De Catalunya Method and computer programs for characterizing ocular accommodation

Also Published As

Publication number Publication date
US20070109498A1 (en) 2007-05-17
US20090161070A1 (en) 2009-06-25
US7490940B2 (en) 2009-02-17

Similar Documents

Publication Publication Date Title
EP1480551B1 (en) Apparatus for objective characterization of vision based on wavefront sensing
US7490940B2 (en) Method for determining objective refraction using wavefront sensing
US8033664B2 (en) Apparatus and method for determining sphere and cylinder components of subjective refraction using objective wavefront measurement
CA2693910C (en) Apparatus and method for determining the required correction for the vision defect of an eye
EP3626157B1 (en) Eyeglass prescription method and system
US6273566B1 (en) Ophthalmologic characteristic measuring apparatus
US6607274B2 (en) Method for computing visual performance from objective ocular aberration measurements
CN107920731B (en) Improved objective comprehensive optometry instrument
US6899428B2 (en) Contrast sensitivity measuring device and contrast sensitivity measuring method
US9775507B2 (en) Method of evaluating quality of vision in examinee's eye and storage medium
Chan et al. Simulating refractive errors: source and observer methods
US20210015356A1 (en) Optometer for Home Use
Labhishetty Accommodative lags and leads: Fact or fiction
Fuller Objective and subjective optometers—their operation and likely impact on optometry

Legal Events

Date Code Title Description
AS Assignment

Owner name: KPCB HOLDINGS, INC., AS NOMINEE, C/O KLEINER PERKI

Free format text: SECURITY INTEREST;ASSIGNOR:OPHTHONIX, INC.;REEL/FRAME:014829/0939

Effective date: 20031126

Owner name: ENTERPRISE PARTNERS VI, L.P., CALIFORNIA

Free format text: SECURITY INTEREST;ASSIGNOR:OPHTHONIX, INC.;REEL/FRAME:014829/0939

Effective date: 20031126

Owner name: DIONIS TRUST, NEW JERSEY

Free format text: SECURITY INTEREST;ASSIGNOR:OPHTHONIX, INC.;REEL/FRAME:014829/0939

Effective date: 20031126

AS Assignment

Owner name: OPHTHONIX, INC., CALIFORNIA

Free format text: RELEASE OF SECURITY AGREEMENT FILED ON DECEMBER 8, 2003.;ASSIGNORS:ENTERPRISE PARTNERS VI, L.P.;KPCB HOLDINGS, INC., AS NOMINEE, C/O KLEINER PERKINS CAUFIELD & BYERS;DIONIS TRUST;REEL/FRAME:014992/0976

Effective date: 20040212

AS Assignment

Owner name: OPHTHONIX, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LAI, SHUI T.;DREHER, ANDREAS W.;REEL/FRAME:016190/0011;SIGNING DATES FROM 20041117 TO 20050125

AS Assignment

Owner name: ENTERPRISE PARTNERS VI, L.P., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:OPHTHONIX, INC.;REEL/FRAME:016926/0145

Effective date: 20050818

AS Assignment

Owner name: OPHTHONIX, INC., CALIFORNIA

Free format text: RELEASE OF INTELLECTUAL PROPERTY;ASSIGNORS:ENTERPRISE PARTNERS VI, L.P.;KPCB HOLDINGS, INC., AS NOMINEE, C/O KLEINER PERKINS CAUFIELD & BYERS;DIONIS TRUST;REEL/FRAME:017186/0500

Effective date: 20051024

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: COMERICA BANK, CALIFORNIA

Free format text: SECURITY AGREEMENT;ASSIGNOR:OPHTHONIX, INC.;REEL/FRAME:021096/0573

Effective date: 20080530